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Abstract 
Background.  Aortic stenosis (AS) is a valvular heart disease that predominantly affects older 
adults.  Valve replacement is the treatment of choice for severe symptomatic AS.  However, 
some older adults cannot undergo open surgical aortic valve replacement (SAVR) due to their 
higher risk for complications.  Over the past decade, transcatheter aortic valve implantation 
(TAVI) has emerged as the recommended therapy for selected high surgical risk patients.  One of 
the main approaches of TAVI, the transapical (TA) TAVI, is often reserved for older adults who 
are not candidates for other surgical procedures because of their increased risk for complications.  
However, the length of hospital stay (LOS) after TA TAVI tends to be longer than other surgical 
procedures. Objective.  The objective of this study was to identify the individual characteristics, 
procedural details, and post-procedure factors predictive of LOS after TA TAVI.  Method.  62 
predictor variables were identified based on literature review, available clinical data, consultation 
with experts.  A retrospective review of 128 consecutive medical charts was then conducted to 
collect relevant data.  Univariate descriptive statistics, bivariate ordinal logistic regression, and 
multivariate ordinal logistic regression analyses were performed to describe the sample and 
examine predictors of LOS.  All relevant Research Ethics Board (REB) approvals were obtained 
prior to the commencement of this study.  Results. The average age of the sample in this study 
was 78.8 years.  57.4% were female older adults.  The mean and median LOS after TA TAVI 
was 11.1 days and 7.0 days, respectively.  Based on the trimmed multivariate model, increased 
age of patients and duration of stay in the critical care unit were associated with prolonged LOS.  
Having chronic lung disease and requiring a temporary pacemaker upon the completion of TA 
TAVI also increased the odds of having longer LOS postoperatively.  Additionally, shorter LOS 
after TA TAVI was associated with higher hemoglobin levels.  In addition, predicted risk of 
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mortality based on the Society of Thoracic Surgeons risk score (STS) was associated with longer 
LOS after TA TAVI, though the sample involving this variable was much smaller due to missing 
data (N= 57).  Conclusion.  This study identified several important individual characteristics, 
procedural details, and post-procedure factors that are associated with increased LOS following 
TA TAVI.  Its findings may alert nurses to heed the implications of these predictors in TA TAVI 
patients and initiate nursing interventions to reduce the risk of prolonged LOS related 
complications.  Future studies are recommended to confirm these findings and the effects of STS 
score and other potential predictors.   
 Keywords:  aortic stenosis, transapical transcatheter aortic valve implantation, length of 
stay, hospital stay 
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Chapter One:  Introduction 
Unprecedentedly, the world population is rapidly ageing.  In Canada, the 2011 Canadian 
Census confirmed that the population of adults aged 65 and over was nearly five millions, and 
this number was projected to double to more than ten million by 2036, reflecting a significant 
demographic shift toward an ageing society (Federation of Canadian Municipalities, 2013).   
With advanced age, many age-related health challenges may occur.  Aortic stenosis (AS), 
the most common valvular heart disease, is predominant in older adults in their seventh to eighth 
decade of life.  In their study, Nkomo and colleagues (2006) confirmed that, in 2000, the 
prevalence of AS in the United States population was 0.7% in  patients between 18 to 44 years 
older, and 13.3% in those who were 75 years and older.  Hence, much effort has been invested in 
pursuing innovative, safe yet cost-effective treatments for AS.  Nearly a decade ago, a minimally 
invasive procedure called transcatheter aortic valve implantation (TAVI) emerged and has 
quickly become a viable therapy for AS in addition to the conventional surgical aortic valve 
replacement (SAVR) (Webb et al., 2012).  At present, there are different accesses used in TAVI 
procedure. Transpical access (TA TAVI) is recommended for patients who are older, sicker, and 
have more peripheral artery disease.  Despite the fact that the overall knowledge of TAVI has 
significantly increased since its inception, particularly in the areas related to its clinical 
application, efficacy, and safety, little has been explored in relation to the length of stay (LOS) 
after TA TAVI.          
1.1  Aortic Stenosis:  Etiology and Treatments 
In AS, the aortic valve progressively narrows with age, thus restricting the output of 
blood to the systemic circulation.  Calcific AS of the trileaflet valve is the most common type in 
older adults and results from an active inflammatory process and progressive calcification.  Other 
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major causes of AS include congenital defects of the bicuspid aortic valve structure and 
rheumatic heart disease.  Clinically, the classic presenting symptoms of severe AS include 
angina, syncope and heart failure.  If left untreated, severe AS can lead to heart failure, impaired 
left ventricular function, decreased quality of life, and even death (Sawaya, Liff, Stewart, Lerakis, 
& Babaliaros, 2012). 
Treatments such as medical management and balloon aortic valvuloplasty alone do not 
provide adequate clinical benefits for patients with severe AS (Lichtenstein et al., 2006; Sawaya 
et al., 2012).  Conventionally, SAVR has been well established as the gold standard treatment for 
symptomatic AS.  Due to advanced age and co-morbidities, however, up to 30% of older adults 
with severe symptomatic AS are believed to be at high risk
1
 for SAVR (Sawaya et al., 2012; 
Webb et al., 2012).  For these people, one of the possible options is TAVI.  Because of different 
approaches of TAVI, the Canadian Cardiovascular Society position statement on TAVI 
recommends that patients who are considered at high risk for SAVR should be evaluated for 
multidisciplinary assessment of their suitability for specific TAVI procedures, including TA 
TAVI (Webb et al., 2012).   
The clinical safety and efficacy of TAVI have been established in the literature.  The 
Placement of AoRtic TraNscathetER Valves (PARTNER) trial randomized non-operable 
patients to either standard medical therapy group or transfemoral TAVI (TF TAVI) group, and 
found that patients in the treatment arm (TF TAVI group) had significant survival benefits 
including reduced mortality rate and improved cardiac sysptoms (Leon et al., 2010).  In their 
study, Smith et al. (2011) found that TAVI was non-inferior to SAVR.  Other clinical trials and 
national registry studies have also served to established TAVI as a safe and viable treatment 
                                                          
1
 Webb et al. (2012) considered that patients would be at high risk for surgery if they had a mortality risk 
of 8% or greater, or major morbidity that was greater than 50% within thirty days of surgery, as predicted 
by experienced cardiac surgeons.   
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option for higher risk patients (Mack et al., 2013; Hamm et al., 2014; Adams et al., 2014; Pighi 
et al., 2014).  In the current clinical practice, the procedure of interest in this study, TA TAVI, is 
often reserved for the patients who are deemed not suitable for other treatments, due to their 
higher surgical risk.    
1.2  TA TAVI 
In the TA TAVI procedure, a small incision is first made at the apex of the heart.  A 
vascular access sheath is subsequently inserted through which a prosthetic heart valve is 
deployed in place by using a balloon-expandable delivery system (Cheung & Lichtenstein, 2012).   
1.2.1  Indications.  Indications for TA TAVI largely depend on the assessment of 
patients’ surgical risk and the expert team’s consensus.  Currently, TA TAVI is often chosen for 
patients who are older, have a higher mean risk score, and have more concomitant health issues, 
thus characterizing a sicker and frailer patient population than those who typically undergo the 
TF TAVI or SAVR (Thielmann et al., 2008; Strauch et al., 2010; Higgins et al., 2011; Walther et 
al., 2012; Lardizabal et al., 2013).   
As compared to other approaches, the TA TAVI procedural approach has certain 
advantages.  For example, several studies indicated that TA TAVI was the preferred treatment 
for high risk older adults, especially those with concomitant renal dysfunction, as TA TAVI 
required significantly less use of contrast media (Bleiziffer et al., 2009; Ewe et al., 2011; 
Madershahian et al., 2012). This feature of TA TAVI is clinically favorable for older adults 
because many of them are susceptible to contrast induced kidney injuries by virtue of advanced 
age and multiple co-morbidities. 
1.2.2  Implications.  Despite the potentially advantageous features of TA TAVI, there 
are risks associated with this procedure.  Pasic et al. (2010) described TA TAVI as "a procedure 
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of 1001 details, a series of small sequences that [needed] to be performed precisely, in perfect 
order, and with perfect timing and excellent coordination between the members of the team" (p. 
1467), indicating that TA TAVI is a complicated procedure, which likely entails heightened 
surgical risk, especially when it is associated with the steep learning curve of performance.   
In addition to the technical challenges of performing this procedure, there are a variety of 
complications and challenges that may arise during the pre-, peri-, and post-procedural periods of 
TA TAVI.  Pasic et al. (2010) identified several preoperative, intraoperative, and postoperative 
problems and difficulties associated with TA TAVI.  Preoperatively, one of the main challenges 
that they encounted was the uncertainty associated with the selection criteria for TA TAVI 
patients.  Intraoperatively, Pasic et al. (2010) stated that procedure-related complications, 
including hemodynamic instability of patients who had severe pulmonary hypertension and poor 
left ventricular function, were the major challenges associated with TA TAVI procedure.  
Neurologic complications were among the major postoperative complications (Pasic et al., 2010).  
At present, within the range of transcatheter options available for treating patients with 
high risk, TA TAVI is often indicated for those with the highest risk, who are not eligible for 
other surgical procedures, including SAVR or TF TAVI, and are characterized by unique 
vulnerabilities and additionally complex care requirements.     
1.3  Statement of Problem 
By the end of 2014, the study center chosen for this study had performed over 1,000 
TAVI procedures and over 200 of these were TA TAVI cases.  The majority of patients who 
underwent TA TAVI procedure were older adults.  While there are various connotations and 
nuances associated with the term of old age, the population of older adults is often defined 
chronologically as pertaining to people who are 65 years old and over.  
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Clinical data showed that TA TAVI patients had longer LOS.  For instance, the median 
reported LOS after TA TAVI was 8.0 days (mean = 12.1 days) in 2011 and 7.0 days (mean = 
10.5 days) in 2013 whereas that of TF TAVI was 4.0 days (mean = 6.2 days) in 2011 and 3.0 
days (mean = 4.6 days) in 2013 (S Lauck, personal communication, March 2014).  Because 
prolonged LOS is hazardous to older patients, we were interested in understanding the factors 
associated with the LOS after TA TAVI.  
1.4  Significance of Problem 
The significance of this study’s focus is twofold.  First, prolonged LOS has important 
implications for institutions, health economics and clinical practice (Khairudin, 2012).  In 
general, there is a consensus that reducing LOS is beneficial for patients, especially older adults 
who are at higher risk for prolonged hospitalization-related complications such as functional 
decline and disabilities, de-conditioning, and nosocomial complications (Kleinpell, Fletcher, & 
Jennings, 2008; Khairudin, 2012).  With an increasingly ageing population, it is anticipated that 
more older adults suffering from symptomatic AS will likely require TAVI procedures.  Because 
the TA TAVI procedure is predominantly reserved for older adults who are not eligible for other 
interventions due to their more advanced peripheral arterial diseases, this patient population is at 
higher risk, more frail and has less overall reserve capacity than those undergoing other 
treatments.  It is anticipated that they are more susceptible to potential consequences of 
prolonged hospitalization.  Hence, identifying the factors of TA TAVI associated with longer 
LOS will likely aid in the pre-procedure planning and may decrease overall LOS by contributing 
knowledge that addresses these predictors of LOS, thus enhancing overall patient care.   
Second, more studies have supported TAVI as an effective, viable alternative when other 
treatments (e.g., conventional SAVR) are not indicated.  With this ever-growing body of 
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knowledge and evidence, it is postulated that the care of TAVI patients could be streamlined and 
standardized by the development of clinical pathways.  The importance of having a clinical 
pathway has been well illustrated in the literature.  Specifically, clinical pathways, as evidence-
based structured multidisciplinary care plans, aim to standardize care for specific clinical 
problems by defining  the time and sequence by which care should be delivered.  The utilization 
of clinical pathways contributes to reduce variations in the multi-faceted health care system, thus 
minimizing the probability of medical errors and ultimately improving patient outcomes 
(Kleinpell et al., 2008).  In the literature, there is currently little information on what factors from 
patients’ individual characteristics, preoperative status and postoperative complications are 
related to LOS after TA TAVI procedure.  Therefore, conducting an analysis of such potential 
factors would further the understanding of the TA TAVI patient population and their care needs, 
which may in turn inform future studies on the pre-procedure planning, practice policy making, 
and clinical pathway development.        
Furthermore, as a major indicator of patient outcome, hospital performance and resource 
consumption, LOS reflects the joint effort of the entire interdisciplinary team, among which 
nursing plays a pivotal role.  Studies have established the association between nurse staffing and 
patient outcomes, including LOS (Kane, Shamliyan, Mueller, Duval, & Wilt, 2007).  Needleman 
and Hassmiller (2009) asserted that “shorter stays reflect not just reductions in complications that 
extend stays, but the ability of nurses to do their work and coordinate the work of others in a 
timely and effective manner” (p.627).  Given the nature of nursing work in the hospital which 
entails carrying out critical tasks including assessing patients, initiating interventions, 
coordinating care, and educating patients and families, it is important for nurses to understand 
what predicts the LOS following TA TAVI for older adults.    
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1.5  Research Question 
This study was designed to use existing clinical data to explore the possible predictors of 
LOS after TA TAVI from the perspective of clinical nursing practice.  By systematically 
analyzing relevant data collected through a retrospective chart review, the study addressed the 
following research question:  To what extent do individual characteristics, procedural details, and 
postoperative factors influence the LOS in older adults who have undergone the TA TAVI 
procedure?   
1.6  Chapter Summary 
 With an ageing population worldwide, it is anticipated that AS will be increasingly 
prevalent in the older population.  TA TAVI, as an emerging minimally invasive intervention, 
has become a viable option for this patient population, especially those who are inoperable for 
other procedures due to their higher surgical risk.  Relevant clinical data showed that, as 
compared to TF TAVI, TA TAVI resulted in longer LOS.  As few studies have explored the 
LOS after TA TAVI, this study aimed to identify what might predict the LOS after TA TAVI 
and to what extent these predictors might be associated with it.   
Chapter Two presents the findings of two literature reviews.  The first literature review 
had a focus on the LOS that was relevant to TA TAVI patient population while the second 
literature review explored the LOS related to general older patient population.  The purpose of 
the literature reviews was to provide the conceptual foundations of this study.  The design of this 
study is described in Chapter Three, illustrating the selection of candidate predictor variables and 
the steps of analytical method.  Relevant ethical considerations are also discussed.  Chapter Four 
presents the results of the statistical analyses of the clinical data collected through a retrospective 
chart review.  The study’s sample and candidate variables are described and the results of 
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bivariate and multivariate ordinal logistic regression models with different variable datasets are 
discussed.  Last, Chapter Five compares the key findings of this study with that of literature 
reviews, evaluates the appropriateness of using the study models specifically designed for this 
study, discusses the implications that this study may have in nursing education and practice, and 
appraises this study’s strengths and limitations.                 
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Chapter Two:  Literature Review 
 The outcome of interest of this study is defined as the total LOS, which refers to the 
period from the commencement of the TA TAVI procedure to the discharge date, excluding 
death.  In this chapter, the findings of two literature reviews are discussed.  The first literature 
review had a focus on the LOS related to TA TAVI whereas the second literature review was 
focused on the LOS in older adults in general.  The purpose of conducting the two literature 
reviews was to appraise the literature findings in relation to the LOS in older adults who 
underwent TA TAVI, identify the variables that potentially influenced the LOS, and provide 
conceptual foundations to this study.    
2.1  LOS in TA TAVI Related Literature 
To gain an understanding of what was currently present in TAVI literature with regard to 
LOS, a literature review was conducted in electronic databases including CINAHL, MEDLINE, 
PubMed, BioMed, and SAGE on December 22, 2013.  The keywords used for searching 
included the combination of 1) “transapical AVI” OR “Transcatheter aortic valve implantation 
transapical” OR “TAVI transapical” OR “TAVI transapical approach” OR “TA TAVI” OR 
“Transapical aortic valve implantation” OR “TAVR2;” 2) “Elder*” OR “older adult” OR 
“geriatric” OR “gerontology” OR “aged” OR “senior;” and 3) “Hospitalization stay?” OR 
“hospital stay” OR “length of hospitalization” OR “length of stay.”  Only articles written in 
English were included.  In addition, the relevant cited references were reviewed and retrieved.  
As a result, a total of 21 articles were included for this review.    
The majority of the identified studies focused on appraising the performing experience of 
TA TAVI procedure or comparing it against other procedures, including SAVR and TF TAVI.  
                                                          
2
 TAVR is the commonly used term for transcatheter aortic valve replacement in the United States while 
TAVI is the term used in Europe and Canada.    
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Several studies explored TAVI related hospital cost.  Among the studies involving LOS-related 
discussion, the LOS after TA TAVI was mostly described numerically and was compared with 
that of other procedures.  The findings involving LOS seemed to vary, depending on many co-
variables such as the performed procedures, the pre-, intra-, or post- procedural variables, study 
perspectives, geographic factors, and health care providers’ clinical preferences.  In the 
following section, the LOS-related findings from the literature review are discussed and 
presented according to the differences among TA TAVI and other procedures, TAVI procedure-
related variables and hospital cost.   
2.1.1  LOS after TA TAVI and other procedures.  Several studies have compared the 
LOS after TA TAVI with that of several other procedures, including TF TAVI, SAVR, and the 
transaortic approach for TAVI (TAo) (Table 1).   
 
Table 1 
Studies Comparing LOS in TA TAVI and Other Procedures 
Study 
Procedure Sample Size 
Compared 
Procedure Mean LOS (days) 
Compared 
p 
Thielmann et al. 
(2009) 
TA TF TA TF 
0.580 
24 15 12 11 
Zierer et al.  
(2009) 
TA SAVR TA SAVR 
<0.001 
21 30 5 12 
Ewe et al.  
(2011) 
TA TF TA TF 
0.210 
59 45 6 6 
Smith et al.  
(2011) 
TAVI SAVR TAVI SAVR 
<0.001 
348 351 8 12 
Higgins et al. 
(2011) 
TA SAVR TA SAVR 
0.205 
46 46 9 8 
Dahle et al.  
(2012) 
TA TF TA TF 
N/A 
25 25 8 7 
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Conradi et al. 
(2012) 
TAVI SAVR TAVI SAVR 
0.110 
82 82 14 11 
Di Mario et al. 
(2013) 
TA TF TA TF 
<0.010 
749 3390 
43.8% had 
LOS >10 days 
22.0%  had 
LOS >10 days 
Lardizabal et al. 
(2013) 
TA TAo TA TAo 
0.140 
76 44 10 8 
Chevreul et al. 
(2013) 
TA Arterial TA Arterial 
N/A 
78 209 
Average LOS:  15 days.   
No significant differences  
in LOS between two groups. 
Note. The values of LOS were uniformly rounded and reported as the mean LOS in days. 
Abbreviations.  TAVI, Transcatheter aortic valve implantation; TA TAVI, Transapical 
transcatheter aortic valve implantation; TF TAVI, Transfemoral transcatheter aortic valve 
implantation; SAVR, SAVR; TAo, Transaortic TAVI; LOS, Length of stay. N/A, Not available.    
 
As shown in Table 1, Thielmann et al. (2009) found longer LOS after TA TAVI (p = 
0.580).  In their study, Di Mario and colleagues (2012) found that the relative frequency of 
patients who had LOS greater than ten days was significantly higher among the patients 
undergoing TA TAVI in comparison to those undergoing TF TAVI.  Likewise, Dahle et al. 
(2012) found a longer mean LOS in TA TAVI patients.  By contrast, Ewe and colleagues (2011) 
found that LOS for both TA TAVI and TF TAVI did not show much difference.   
When compared with conventional SAVR, Zierer and colleagues (2009) found that 
patients undergoing TA TAVI had significantly shorter operation time, ventilation time, 
intensive care unit stay and overall hospital LOS.  Moreover, the randomized control trial report 
by Smith et al. (2011) on behalf of the PARTNER investigators found that patients in the TAVI 
group had significantly shorter overall LOS.  By contrast, Higgins et al. (2011) used propensity 
scoring to match up the patients of TA TAVI group with those of SAVR group.  They concluded 
that there were no significant differences in LOS between the two matched-up groups.  Similarly, 
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the propensity scoring analysis of Conradi and colleagues (2012) confirmed that TAVI, 
including transapical and transfemoral approaches, resulted in shorter time with regard to 
operative time, ventilation time, and stay in the intensive care unit.  
Lardizabal et al. (2013) found that there was no significant difference in LOS between 
TA TAVI group and transaortic approach for TAVI group, which used transaortic access to 
perform TAVI.  Moreover, a multicenter national registry data analysis by Chevreul et al. (2013) 
on 287 patients undergoing TAVI procedures (TA TAVI and TAVI using arterial access) 
showed that mean LOS did not significantly differ between groups.   
Overall, studies report varying results of LOS in patients undergoing TA TAVI.  Despite 
one study showing significantly shorter LOS following TA TAVI procedure, other studies have 
consistently revealed a longer LOS in patients undergoing TA TAVI regardless of the comparing 
procedures.   
2.1.2  TA TAVI-related variables.  In the literature, clinical variables related to TA 
TAVI, including procedural complications and patient’s individual characteristics seemed to play 
a role in influencing LOS.  One of the common post-TAVI complications, acute kidney injury 
due to the use of contrast media, has been examined in several studies.  Based on a sample of 
261 patients who had TA TAVI, Van Linden et al. (2011) reported that acute kidney injury did 
not significantly prolong LOS.  This finding is consistent with that of Strauch et al. (2010).  
Madershahian et al. (2012) reported that in TA TAVI the doses of contrast media used intra-
procedurally did not result in significant difference in LOS.  However, Van Linden et al. (2011) 
found that, when older adults had acute kidney injury, those who required the renal replacement 
therapy had significantly longer LOS than those who did not require renal replacement therapy.  
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Other procedural factors including blood transfusion and general anaesthesia were also found to 
be associated with prolonged LOS (Di Mario et al., 2012; Mwipatayi et al., 2013)  
Practice experience of surgeons seemed to influence LOS in TA TAVI patients as well.  
In their initial TA TAVI experience of 12 patients, Spargias et al. (2008) reported that average 
LOS was eight days.  The authors argued that those patients were kept in the hospital for longer 
observations because the surgeons were new to this procedure.  Conradi and colleagues (2012) 
stated that one of the reasons underlying the unreduced overall LOS in their study was the 
extended period of continuous telemetry monitoring postoperatively for observing conduction 
disorders in TA TAVI patients.  Interestingly, based on a sample of 287 people, Chevreul et al. 
(2013) found that LOS decreased from a median of thirteen days  in the first third of the sample 
to eleven days in the last third of the sample, indicating the possible existence of learning curve 
associated with the innovative TA TAVI procedure.  Nonetheless, because only a few studies 
explored surgeons’ experience, especially in the early stage of clinical application of TA TAVI, 
caution is needed in inferring that variations in surgeons’ experiences of performing TA TAVI 
are associated with LOS.   
In addition, Dahle et al. (2012) argued that prolonged LOS might be associated with 
logistical challenges and geographic differences.  For example, some of their patients had to be 
kept longer in hospital due to their complicated transportation arrangements.   
In conclusion, research has examined several variables related to the LOS after TA TAVI.  
Factors, including use of general anaesthesia, blood transfusion, and acute kidney injury-induced 
renal replacement therapy, tended to prolong LOS while acute kidney injury itself seemed not to 
affect the LOS.  Other possible factors associated with prolonged LOS included surgeons’ 
practice and experiences related to this procedure and patients’ transitional care arrangements 
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due to their geographic locations.  Nevertheless, with regard to the LOS, the impact of many 
other factors such as procedure-related complications (e.g., postoperative bleeding) and older 
adults’ co-morbidities or functional status has not been examined in current TA TAVI literature, 
indicating the needs for further research in this area.     
2.2  LOS in Older Adults:  General 
There is a paucity of research taking into consideration the associations between the 
characteristics of TA TAVI patients, especially co-morbidities and health conditions (i.e., 
functional ability and frailty), in relation to LOS.  Moreover, because TA TAVI patients are 
typically older, it is useful to appraise in general what the common issues related to LOS are in 
older adults.  The underlying rationale for conducting this literature review was therefore twofold.  
First, understanding how prolonged LOS would affect older adults in acute care settings in 
general might help to appreciate what may impact older adults undergoing TA TAVI.  In other 
words, if literature generally agreed that prolonged LOS could significantly impact older people, 
then exploration of TA TAVI related LOS might have meaningful clinical implications.  Second, 
as TA TAVI is primarily indicated for older older adults, exploring LOS in older adults from a 
more general point of view might help with identifying the relevant variables relevant to LOS 
after TA TAVI as well as developing the theoretical thinkings for conducting this study.    
The second literature review of LOS in older adults in general was conducted in both 
CINAHL and MEDLINE on December 22, 2013.  The keywords included “older adult” OR 
“senior” OR “aged 65+,” and “length of hospitalization” OR “length of stay,” and “review” OR 
“literature review” OR “systematic review.”  Only reviews published in peer reviewed journals 
in English between 2008 and 2013 were included.  Cited references were also reviewed and 
searched if relevant.  Initially, there were a total of twenty articles retrieved, of which eleven 
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studies were finally selected for the review.  The findings are presented below from the 
perspective of how LOS was related to patient’s individual characteristics including advanced 
age and co-morbidities, iatrogenic complications, functional status, and frailty.   
2.2.1  Advanced age and co-morbidities.  Advanced age is an important factor in 
influencing the LOS in older adults in general.  Studies have shown that age was an independent 
predictor for prolonged LOS in the older patients (Kaysar et al., 2008; Kofteridis et al., 2009; 
Morse, Boland, Blackhurst, & Roettger, 2010).  Kaysar et al. (2008) studied age in relation to 
community-acquired pneumonia and found that, compared to younger counterparts, older adults 
were more likely to have severe pneumonia and longer LOS.  Similarly, Kofteridis et al. (2009) 
reported that age played a role in older adults with diabetes mellitus and made them more 
susceptible to nosocomial infections such as urinary tract infection.  More importantly, in their 
study, Morse et al. (2010) found that, compared to younger patients, those aged 80 and older had 
a statistically higher incidence of catheter-related urinary tract infection, vascular catheter 
infection, longer hospital LOS, and greater median hospital cost.  
Another prominent factor in influencing LOS is the co-morbidities status of older adults.  
Kofteridis et al. (2009) confirmed that diabetes mellitus was independently predictive of 
bacteremia and urinary tract infection in the hospitalized older adults, leading to longer 
hospitalization and higher mortality.  Moreover, co-morbidities often resulted in polypharmacy 
in older adults, which was in turn associated with increased risk of prescription errors, and 
temporary harm, and required more interventions, thus further complicating older adults’ care 
during hospitalization (Yong, Lau, Li, Hakendorf, & Thompson, 2012).   
In addition, the complex nature of older care was evident in several studies on the 
effectiveness of specialty care for hospitalized older adults.  In their evaluation of the 
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effectiveness of an unique pharmacist-led program, Mortimer, Emmerton, and Lum (2011) found 
that LOS of older adults involved in this program was longer than that of those who were not 
involved.  Although confounding was likely, Mortimer et al. argued that the reasons for 
prolonged LOS likely lay in the fact that those patients involved in the program received more 
attention from the pharmacist who demonstrated greater vigilance while assessing and 
monitoring patients’ polypharmacy issues, indicating the need for more specialized, 
individualized care in older populations.  Considering LOS as one of the efficiency 
measurements, Sorbero, Saul, Liu, and Resnick (2012) compared the outcome between 
geriatrician-led care and non-geriatrician-led care for hospitalized older adults.  They found that 
older adults benefited from more specialty care, which led to more diagnoses, shorter LOS, and 
lower cost per admission. 
In summary, the literature review showed that advanced age and co-morbidities with the 
possibility of concurrent polypharmacy were consistently associated with prolonged LOS in 
hospitalized older adults.  Specialized geriatric care models and programs seemed to have 
inconclusive impact on LOS in older adults.       
2.2.2  Iatrogenic complications.  In the literature, there was a consensus that, once 
iatrogenic complications occurred during hospitalization, older adults were at greater risk for 
mortality, delayed recovery, and prolonged LOS (Kaye et al., 2009; Bjorkelund, Hommel, 
Thorngren, Lundberg, & Larsson, 2011).  Specifically, Kaye et al. (2009) identified the positive 
correlation between surgical site infection and mortality risk and prolonged LOS in older adults.  
Moreover, in older adults having hip fractures, Bjorkelund et al. (2011) found that postoperative 
complications, including anemia-induced blood transfusion, were associated with prolonged 
LOS.   
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Furthermore, lower Braden Scale
3
 scores, computed by the well-established Braden Scale, 
usually indicated greater risk for developing pressure sores (Bergstrom, Braden, Laguzza, & 
Holman, 1987).  By analyzing 102 older adults undergoing abdominal surgeries, Cohen et al. 
(2012) concluded that lower Braden Scale scores were predictive of thirty-day postoperative 
complications, longer LOS, and discharge to institution or nursing home rather than to the 
patient’s home.    
2.2.3  Functional and frailty status.  Several studies have documented the course of 
functional decline in hospitalized older adults (Callen, Mahoney, Wells, Enloe, & Hughes, 2004; 
Kleinpell et al., 2008; Lafont, Gerard, Voisin, Pahor, & Vellas, 2011).  However, the literature, 
that examined LOS in relation to functional decline in hospitalized older adults, lacks 
consistency because there is no consensus on measurements for assessing functional status.  
Regardless, it is generally agreed that preventing or mitigating functional decline for older adults 
while hospitalized likely reduces LOS.  One clinical intervention recommended in the literature 
is early implementation of physical exercise programs (i.e., early physical rehabilitation 
programs) for hospitalized older adults.  The study of Kosse and colleagues (2013) showed that 
early physical rehabilitation programs improved hospitalized older adults’ physical functional 
performance, thus reducing overall LOS and increasing the likelihood of being discharged home 
rather than to facilities with nursing care.    
Though conceptually distinct, functional status is closely interrelated with frailty status.  
This has been exemplified by the use of the Braden Scale with hospitalized older adults.  A 
number of studies showed that the Braden Scale scores were indicative of both functional status 
                                                          
3
 The Braden Scale is a clinical assessment tool used for predicting the development of pressure ulcers.  It 
sums a total score from six to 23 by assessing risk in six areas (sensory perception, skin moisture, activity, 
mobility, nutrition and friction/shear).  The lower the score is, the higher the risk for developing a 
pressure ulcer.  Its psychometric properties have been established (Bergstrom, Braden, Laguzza, & 
Holman, 1987; Kring, 2007).   
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and frailty of older adults.  And lower Braden Scale scores were associated with greater 
functional decline in hospitalized older adults (Kleinpell et al., 2008; Lafont et al., 2011).  
Comparing the Braden Scale with several proposed frailty models in the literature, Cohen et al. 
(2012) confirmed that the six domains of the Braden Scale corresponded well with the widely 
accepted phenotypic features of Frailty Syndrome, including poor cognition, weakness, sense of 
exhaustion, and weight loss (Fried et al., 2001).  In addition, they found that lower Braden Scale 
scores are associated with functional decline.  Moreover, Cohen el al. (2012) stated that 
functional decline in older adults while hospitalized was indicative of a frailer status, and was 
associated with more postoperative complications, longer LOS and higher incidence of altered 
level of care (i.e., discharging to a nursing home instead of their own home).     
2.3  Conceptual Foundations of Study 
In this section, we summarize the findings of literature review that help with variable 
identification and provide conceptual thinking relevant to this study.   
Overall, the LOS after TA TAVI is understudied.  Despite being inconclusive, the 
majority of literature has observed a longer LOS in TA TAVI patients, especially while 
compared to other TAVI procedures.  The factors of LOS that have been explored in the 
literature include individual characteristics of patients (i.e., transitional care arrangements); TA 
TAVI’s peri-procedural factors (i.e., the use of general anaesthesia); post-procedural 
complications (i.e., acute kidney injury, vascular access complications and the need for blood 
transfusion); and finally, the surgeons’ experiences and familiarity with this procedure.   
The literature review suggests that many other factors that could possibly influence LOS 
in patients undergoing TA TAVI.  For instance, the characteristics of older adults, including 
advanced age and co-morbidities and frailty status, were intrinsically associated with the 
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susceptibility for prolonged LOS.  A longer LOS, in turn, could contribute to undesirable 
outcomes, including functional decline, disabilities and even death (Kleinpell et al., 2008; Lafont 
et al., 2011).  Specific to TA TAVI, Thielmann et al. (2009) suggested that “factors like social 
integration, mobility, frailty, and individual overall health status" be taken into account to 
carefully evaluate TAVI patients preoperatively (p. 1473), indicating the existence of multiple 
variables related to the LOS after TA TAVI, and the need for more studies.   
Overall, the various LOS-related variables reported in the literature correspond with the 
following categories, which are further described below:  patient’s individual characteristics and 
procedure-related features and complications.        
2.3.1  Individual characteristics.  To understand the impact of patient’s individual 
characteristics, it is helpful to first define what individual characteristics might be included.  In 
the literature, individual characteristics have been defined, including demographic, 
developmental, psychological and biological factors.  All of these could potentially affect 
biological function, which, in turn, could impact functional ability and quality of life (Ferrans et 
al., 2005).  Other important components of individual characteristics include environmental 
factors, which could be divided into two categories:  social and physical (Ferrans et al., 2005).  
Studies have shown that interpersonal relationships of older adults with their families, friends, 
and health care providers have a strong influence on their overall health.  In addition, it is widely 
accepted that hospital environments are not conducive to optimal recovery, especially for older 
adults who lack appropriate social support (Ferrans et al., 2005; Cohen et al., 2012).   
In addition, functional and frailty status are considered important individual 
characteristics.  In the literature, there is a consensus that prolonged hospitalization is a 
significant event for older adults because it is closely associated with functional loss, de-
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conditioning and serious multi-system complications (i.e., muscle mass loss and malnutrition) 
(Kleinpell et al., 2008; Lafont et al., 2011; Khairudin, 2012).  Related to LOS, several studies 
affirmed that Frailty Syndrome is prevalent in older adults and is associated with more 
hospitalization-related functional disabilities and complications, and prolonged LOS (Ahmed, 
Mandel, & Fain, 2007; Dasgupta, Rolfson, Stolee, Borrie, & Speechley, 2009; Noimark, 2009; 
Puts et al., 2010; Lafont et al., 2011; Cohen et al., 2012).     
Surprisingly, few characteristics of TA TAVI patients, other than geographic location, 
have been explored with regard to their impact on LOS.  Given that TA TAVI is mainly 
indicated for older adults with higher risk, whose frail status is typically characterized by 
declined physiological and functional reserve and complex co-morbidities status, it is anticipated 
that these individual characteristics could impact the LOS after TA TAVI patients.   
2.3.2  Procedure-related characteristics.  TA TAVI is an innovative but complex, 
sophisticated procedure.  Literature about the Peri-procedure phase shows that a variety of 
factors might influence the procedure’s outcome, including LOS.  Examples of these factors 
include the use of general anaesthesia, the need for blood transfusion, and the experience of the 
surgeons’ performing the procedure.  This area, however, remains underexplored.  Given 
consideration to the high-risk nature of the TA TAVI procedure and its target patient 
population’s frail status, it is postulated that procedure-related factors (i.e., the use of invasive 
equipment or chest tube) could impact the LOS after TA TAVI.   
Several common post-TA TAVI complications have also been identified in the literature.  
These include stroke, postoperative atrioventricular block, postoperative bleeding, acute kidney 
injury, wound infection, vascular complications, postoperative atrial fibrillation, postoperative 
myocardial infarction, delirium, and heart failure.  Other less common complications include 
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prosthesis related issues, para-valvular leak, tamponade, and pleural effusion (Kappetein et al., 
2012).  Among these complications, acute kidney injury has been studied in several studies with 
regard to its impact on the LOS after TA TAVI (Strauch et al., 2010; Van Linden et al., 2011; 
Madershahian et al., 2012).  Other studies have found that vascular complications are common in 
TA TAVI patients and associated with higher incidence of blood transfusion and thus prolonged 
LOS (Webb et al., 2009; Smith et al., 2011; Mwipatayi et al., 2013).  Nonetheless, many post-
procedural complications remain underexplored, thus giving rise to this study.     
2.4  Study Models 
Because no LOS-related conceptual frameworks were found in the literature that were 
applicable to this study, and based on the findings of the literature reviews and the consultation 
with the clinical data and experts, we developed the Predicting LOS after TA TAVI:  TA TAVI 
Surgical Process Model (Figure 1) to be used as the underlying conceptual thinking for this study. 
As shown in Figure 1, the timeline of a TA TAVI patient’s surgical process was divided 
into three phases prior to discharge.  To help with defining the three phases, five key points of 
time were defined as follows:  1) “Date of Referral”  was defined as the date when the TA TAVI 
patient was referred to the Transcatheter Heart Valve (THV) program at the study center of this 
study; 2) “Date of Acceptance” was defined as the date on which the TA TAVI patient was 
accepted into the THV program; 3) “Procedure Start Time” was defined as the start time of the 
TA TAVI procedure; 4) “72-hour Post-op” was defined as the time of occurring 72 hours after 
the start time of the TA TAVI procedure, excluding the time point of 72 hours; and 5) “Date of 
Discharge” was defined as the date on which the patient was discharged alive in this study. 
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Figure 1.  Predicting LOS after TA TAVI:  TA TAVI Surgical Process Model.  This figure 
illustrates the three consecutive phases of TA TAVI procedure surgical process defined in this 
study.  
 
Building on the TA TAVI Surgical Process Model (Figure 1), we postulated that the three 
phases might be interrelated, and could exhibit a cumulative effect on LOS.  Meanwhile, each of 
the three phases might individually impact LOS to varying degrees.  To describe and categorize 
these relevant variables, we then developed the Predicting LOS after TA TAVI:  Conceptual 
Model (Figure 2).  This model includes the categories of variables that have been previously 
explored in the literature.  Considering the exploratory nature of the predictors of LOS in this 
population, other potentially relevant variables were added to each category.  We therefore 
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present the following possible candidate variables by using the conceptual modal above and 
propose that these variables could be associated with the LOS after TA TAVI.      
 
Figure 2.  Predicting LOS after TA TAVI:  Conceptual Model.  This figure illustrates this 
study’s conceptual model.  
 
2.4.1  Pre-procedure phase.  The Pre-procedure phase was defined as the period from 
the “Date of Referral” to the “Procedure Start Time” (Figure 1).  Variables during this phase 
were further categorized under four subgroups:  Demographics, History and Risk Factors, 
Functional Assessment, and Pre-op Status.   
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First, the Demographics subgroup included variables pertaining to patients’socio-
demographic characteristics and TA TAVI procedure preparation information prior to the 
“Procedure Start Time” (Figure 1).  Thus, examples of such variables included age and gender, 
geographic location, preoperative health status, and TA TAVI procedure specific variables such 
as wait time related variables.  
Second, the History and Risk category described patients’ previous medical history and 
co-morbidities prior to the “Date of Acceptance” as shown in Figure 1.  Examples included 
previous cardiac surgeries, chronic lung diseases, prior stroke history and the like.   
The third category pertained to patients’ functional sssessments.  In fact, functional status 
is a complex phenomenon that can be measured by a plethora of functional assessment 
instruments and approaches.  Leidy (1994) defined functional status as “a multidimensional 
concept characterizing one’s ability to provide for the necessities of life” (p. 197).  In this study, 
the category of Functional Assessment specifically refers to TA TAVI patients’ preoperative 
functional and frailty status prior to the “Date of Acceptance,” as well as living environment and 
home support services received prior to the TA TAVI procedure.  Examples of the Functional 
Assessment variable included the Activities of Daily Living (Katz, Down, Cash, & Grotz, 1970).       
Last, the Pre-op Status variables pertained to TA TAVI patient’s preoperative health 
conditions.  Variables included surgical risk factors and preoperative laboratory results 
completed within two weeks before the “Procedure Start Time”.  Examples of such variables 
included the Left Ventricle Ejection Fraction (LVEF) and the New York Heart Association 
classification (NYHA) (American Heart Association, 2015).  Preoperative laboratory values (i.e., 
preoperative serum hemoglobin and creatinine levels) were also included.      
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2.4.2  Peri-procedure phase.  The Peri-procedure phase was defined as the period from 
the “Procedure Start Time” to the point of “72-hour Post-op.”  This phase included variables 
describing the procedural factors of TA TAVI, major postoperative complications, characteristics 
of patients’ immediate postoperative status, and relevant required critical care.  The selection of 
the time frame for reporting peri-procedure events reflected the standard set by the Society of 
Thoracic Surgeons/ American College of Cardiology Transcatheter Valve Therapy (STS/ACC 
TVT) Registry (version 1) established to monitor outcomes (Mack et al., 2013).  Examples 
included TA TAVI procedure operation time, types of heart valve operated, use of chest tube 
upon the completion of the procedure and the like.  Major complications, including annular 
dissection and tamponade, new conduction or native pacer disturbances, bleeding and blood 
transfusion, were included as well (Figure 1 & Figure 2).     
2.4.3  Post-procedure phase.  The Post-procedure phase was defined as the period from 
the point of “72-hour Post-op” to the “Date of Discharge.”  Similar to those defined in the Peri-
procedure phase, variables in this phase described major postoperative complications and 
relevant patient-care factors from the time of 72 hours after the TA TAVI procedure until 
discharge.  Examples included complications such as stroke, cardiac arrest, bleeding, incidence 
of atrial fibrillation, and the like (Figure 1 & Figure 2).   
2.5  Research Objective 
Based on the proposed Predicting LOS after TA TAVI:  TA TAVI Surgical Process 
Model (Figure 1) and Predicting LOS after TA TAVI:  Conceptual Model (Figure 2) above, the 
objectives of this study were as follows:  1) to identify the factors predictive of the LOS after TA 
TAVI; and 2) to evaluate the relative importance of these factors in predicting LOS. 
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2.6  Chapter Summary 
In this chapter, we present the results of two literature reviews that were conducted in this 
study.  The first literature review specifically focused on the LOS after TA TAVI while the 
second one had a broader focus on LOS-related literature in the general older population.   
Overall, the LOS after TA TAVI is understudied.  Several studies reported that TA TAVI 
seemed to result in longer LOS.  A number of factors have been explored in association with 
longer LOS after TA TAVI.  These include types of anaesthesia, blood transfusion, acute kidney 
injury related treatments, and healthcare providers’ experience.  In general, there is consensus 
that patients’ individual characteristics, including advanced age and functional status, influence 
the LOS.  In addition, literature has indicated that, as an innovative but complex procedure, the 
characteristics of TA TAVI might impact the LOS.  To conceptually organize various factors 
potentially relevant to TA TAVI in this study, we developed two models, the Predicting LOS 
after TA TAVI:  TA TAVI Surgical Process Model (Figure 1) and the Predicting LOS after TA 
TAVI:  Conceptual Model (Figure 2), by which the process of TA TAVI surgical process was 
divided into three consecutive phases, namely, the Pre-procedure phase, the Peri-procedure phase, 
and the Post-procedure phase.  Accordingly, examples of potential variables under the three 
phases were discussed.  In the following chapter, we proceed to discuss this study’s method.     
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Chapter Three:  Method 
3.1  General Description of Research Design 
 This study analyzed the data retrieved through a retrospective chart review.  The 
appropriateness of using this design in this study is discussed as follows.  
In the literature, the terms of medical record review and chart review are often 
interchangeable.  Worster and Haines (2004) defined “medical record review” as studies that 
“use pre-recorded, patient-focused data as the primary source of information to answer a research 
question” (p.1).  This methodology had its inherent strengths as well as weaknesses (Worster & 
Haines, 2004; Gearing, Mian, Barber, & Ickowicz, 2006).  The main strengths included 1) the 
availability of a wealth of clinical data that had been already collected; and 2) the 
appropriateness of addressing research questions that could not be answered via randomized 
prospective trials due to potential harm and/or benefits.  The main concern with the method of 
medical chart review lay in the reproducibility and validity of the data collected (Worster & 
Haines, 2004; Gearing et al., 2006).  It is recognized that subjective interpretations of medical 
records may vary.  In addition, conflicting or missing data are common and pose potential threats 
to data quality.  Several research strategies have been proposed to mitigate such threats and 
ensure the reliability of data.  The use of explicit and objective criteria was one of the strategies 
that minimized the risk of varying subjective interpretations (Worster & Haines, 2004).  In 
addition, Gregory and Radovinsky (2012) argued that the use of rigorous data collection methods, 
including the precise data collection tool and coding manual, correlated to the reliability of data 
and studies.   
Since the objectives of this study did not involve evaluating the outcomes of an 
intervention, a randomized controlled trial was not appropriate.  In addition, much of the 
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information were already recorded in the medical records.  Therefore, using the chart review was 
considered more feasible and efficient to conduct an analysis of the data for answering this 
study’s research question.  Furthermore, as the majority of variables involved in this study were 
objectively defined and explicitly measured, a retrospective chart review was appropriate in this 
regard.  To ensure the consistency in data extraction and enhance the quality of data extracted, 
the Data Collection Form (Appendix A) and the Code Manual (Appendix B) were also 
developed.   
3.2  Study Sample and Eligibility Criteria 
This study’s sample included the 128 consecutive medical records of patients who had 
TA TAVI at the study center from 2010 to 2014.  A power analysis revealed that, when using 
multivariate logistic regression, a sample of 120 was required for analyzing 12 covariates 
(Peduzzi, Concato, Kemper, Holford, & Feinstein, 1996).       
This study’s eligibility criteria were as follows:  patients who were 65 years old and over, 
had symptomatic AS, were accepted by the THV program, underwent TA TAVI procedure at the 
study center from 2010 to 2014, and were discharged alive.      
3.3   List of Variables 
As discussed in Section 2.4, in consideration of the literature review and the consultations 
with clinical experts, as well as the data available in the medical records, a collection of 62 
candidate independent variables (Table 2) were selected and classified according to the 
Predicting LOS after TA TAVI:  TA TAVI Surgical Process Model (Figure 1) and the Predicting 
LOS after TA TAVI:  Conceptual Model (Figure 2).   
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Table 2 
List of 62 Independent Variables 
Pre-procedure Phase Variables 
    
Demographic Variables 
 
Functional Assessment Variables 
 
Age 
  
Home Support 
 
 
Sex 
  
Living Situation 
 
 
Status of Referral 
 
CSHA CFS 
  
 
Location of Residence 
 
ADL 
  
 
WaitTime1 
  
IADL 
  
 
WaitTime2 
  
MMSE 
  
 
WaitTime3 
  
Mean 5-m Walk 
 
History and Risk Factors Variables Pre-op Status Variables 
 
 
Prior PPM 
  
NYHA 
  
 
Prior ICD 
  
LVEF 
  
 
Chronic Lung Disease 
 
STS 
  
 
Diabetes 
  
BMI 
  
 
Prior Stroke 
  
Hgb 
  
 
Prior MI 
  
Creatinine 
 
 
Prior Atrial Fibrillation 
 
eGFR 
  
 
Prior Other Cardiac Surgery 
    
 
Prior CABG 
     
 
Prior PCI 
     
 
Prior SAVR 
     
 
Prior BAV 
     
Peri-procedure Phase Variables 
    
Procedural Factors Variables Peri-Procedure Complications Variables 
 
Procedure Total Time 
 
≤72hr Pacemaker 
 
 
Valve Type 
  
≤72hr Atrial Fibrillation 
 
Procedure Type 
  
≤72hr Stroke 
 
Peri-Procedure Status Variables 
 
≤72hr Annular Dissection 
 
Airway Status 
  
≤72hr Cardiac Arrest 
 
 
Pulmonary Artery Catheter 
 
≤72hr Perforation 
 
 
Chest Drain 
  
≤72hr Bleed 
 
 
Temporary Pacemaker 
 
≤72hr Blood Transfusion 
    
≤72hr Blood Transfusion Units 
Post-procedure Phase Variables 
    
LOS in Critical Care Variable 
 
Post-Procedure Complications Variables 
 
LOSICU 
  
>72hr Pacemaker 
 
Discharge Planning Variables 
 
>72hr Atrial Fibrillation 
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Lowest Hgb 
  
>72hr Stroke 
 
 
Discharge Hgb 
  
>72hr Cardiac Arrest 
 
 
Highest Creatinine 
 
>72hr Perforation 
 
 
Discharge Creatinine 
 
>72hr Bleed 
 
    
>72hr Blood Transfusion 
    
>72hr Blood Transfusion Units 
Abbreviations.  PPM, permanent pacemaker; ICD, implantable cardioverter defibrillator; 
MI, myocardial infarction; CABG, coronary artery bypass surgery; PCI, percutaneous 
coronary intervention; SAVR, SAVR; BAV, balloon aortic valvuloplasty; CSHA CFS, 
Canadian Study of Health and Aging Clinical Frailty Scale; ADL, Activities of Daily 
Living; IADL, Instrumental Activities of Daily Living; MMSE, Mini Mental State 
Examination; Mean 5-m Walk, mean 5-m Gait Speed test score; NYHA, New York Heart 
Association functional classification; LVEF, Left Ventricular Ejection Fraction; STS, the 
Society of Thoracic Surgeons risk score; BMI, Body Mass Index; Hgb, hemoglobin; eGFR, 
estimated Glomerular Filtration Rate; ≤72hr, less than or equal to the first 72 hours after 
TA TAVI ; >72hr, more than 72 hours after TA TAVI procedure. 
 
3.4   Level of Measurement of Variables 
As the levels of measurement of the majority of the 62 variables are self-explanatory, for 
example, the Demographic and History and Riosk Factors variables describe the TA TAVI 
patients’ age, sex and medical histories, which are mostly categorical variables.  In the following 
sections, we discuss the levels of measurement of a number of variables that are either modified 
for or specific to this study:  1) three modified ordinal-level variables, namely, LOS ordinal, 
≤72hr Blood Transfusion Units and >72hr Blood Transfusion Units); and 2) the variables 
specifically used in the THV program at the study center, which include the following:  a) Wait 
Time variables, including WaitTime1, WaitTime2, and WaitTime3; b) the Functional Assessment 
variables, including the Gait Speed test (Mean 5-m Walk) (Wilson, Kostsuca, & Boura, 2013); 
the Activities of Daily Living (ADL) (Katz et al., 1970); the Instrumental Activities of Daily 
Living (IADL) (Lawton & Brody, 1969); the Mini-Mental State Examination (MMSE) (Folstein, 
Folstein, & McHugh, 1975); and the Canadian Study of Health and Aging Clinical Frailty Scale 
(CSHA CFS) (Dalhousie University Faculty of Medicine, 2012); and c) the Pre-op Status 
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variables, including New York Heart Association Classification (NYHA) (American Heart 
Association, 2015); and the Society of Thoracic Surgeons risk score (STS) (The Society of 
Thoracic Surgeons, 2014).  
3.4.1  LOS ordinal.  The dependent variable of this study was LOS, which was defined 
as the total days of one’s hospital stay from the date of the TA TAVI procedure to the date of 
discharge.  It was originally a continuous-level variable, which was highly skewed.  To mitigate 
for these distributional challenges and to facilitate interpretation of the results, the original 
variable was converted into an ordinal-level variable, LOS ordinal, consisting of four 
approximately equal quartiles (Table 3).     
 
Table 3 
LOS Ordinal 
LOS Ordinal Level 
LOS is between 1 - 5 days 1 
LOS is between 6 - 7 days 2 
LOS is between 8 - 12 days 3 
LOS is 13 days and more 4 
Abbreviation.  LOS, length of stay.  
 
3.4.2  Blood transfusion units variables.  Similar to the dependent variable, LOS 
ordinal, the two blood transfusion units related variables were converted from continuous level 
to ordinal level.  The variable of ≤72hr Blood Transfusion Units was defined as the total units of 
blood product that TA TAVI patient received within the first 72 hours postoperatively while the 
variable of >72hr Blood Transfusion Units was defined as the total units of blood products that 
TA TAVI patient received 72 hours after the completion of the procedure.  As shown from the 
original data, when blood transfusion was indicated after the TA TAVI procedure, the total units 
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of given blood products varied within a small range of one to five units.  Therefore, it was more 
pragmatic to convert them to ordinal type for the purpose of statistic analysis (Table 4).   
 
Table 4 
Blood Transfusion Units Variables:  Ordinal Level 
Variables Level 
≤72hr Blood Transfusion Units 
       More than 1 unit 1 
      1 unit 2 
      None 3 
>72hr Blood Transfusion Units 
       More than 1 unit 1
      1 unit 2 
      None 3 
Abbreviations.  ≤72hr, less than or equal to the first 72 hours after TA 
TAVI  procedure; >72hr, more than 72 hours after TA TAVI procedure. 
 
3.4.3  Wait time variables.  In the THV program at the study center, there was a 
screening and referral process by which TA TAVI candidates were evaluated.  Generally, 
patients were first referred to the program and evaluated for acceptance.  On the acceptance day, 
the multidisciplinary Heart TA TAVI candidates completed the preoperative assessments at the 
center, and were given the date of the TA TAVI procedure.  Hence, in this study, Wait Time 
variables consisted of three variables, namely, WaitTime1, WaitTime2, and WaitTime3.  The 
variable of WaitTime1 was defined as the duration from the Date of Referral to the THV program 
until the Date of Acceptance.  The variable of WaitTime2 was defined as the time period from 
the Date of Acceptance to the date of TA TAVI.  And the variable of WaitTime3 was defined as 
the total sum of WaitTime2 and WaitTime3.  All three variables were continuous and were 
measured and recorded in days.   
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3.4.4  Functional assessment variables.  As discussed previously, TA TAVI patients are 
usually more frail and vulnerable due to a constellation of risk factors.  Despite the fact that there 
are controversies around measurements used for frailty assessment in the literature, frailty is 
generally defined as a multi-factorial geriatric syndrome that develops over time as a result of an 
accumulation of stressors and that results in a reduced ability to maintain or regain homeostasis 
at advent of a destabilizing event (i.e., undergoing surgery or hospitalization).  One of the 
commonly accepted measurements for frailty assessment involved the use of the following five 
criteria:  unintentional weight loss (ten pounds in past year), self-reported exhaustion, weakness 
(grip strength), slow walking speed, and low physical activity.  To determine whether one is frail, 
at least three of these five criteria must be met (Fried et al., 2001; Ferrucci et al., 2004).  
Moreover, according to Leidy (1994), functional status consisted of four dimensions:  functional 
capacity, functional performance, functional capacity utilization, and functional reserve.  One’s 
functional capacity indicated his/her ability of performing activities in the physical, social, 
psychological or cognitive domains, which likely influenced the outcome of treatments and 
interventions.  Hence, the inclusion of functional assessments preoperatively has gained more 
popularity in TAVI related literature (Green et al., 2012; Schoenenberger et al., 2012).   
In the THV program, four functional assessment instruments were routinely utilized, 
including the Gait Speed (Wilson et al., 2013); ADL (Katz et al., 1970); IADL (Lawton & Brody, 
1969); MMSE (Folstein et al., 1975); and CSHA CFS (Dalhousie University Faculty of 
Medicine, 2012).  In the following section, the psychometric properties of the five instruments 
are briefly discussed.    
3.4.4.1  Gait Speed.  Gait Speed is used as a frailty clinical marker and is commonly 
measured by the 5-m Walk test.  Recorded in seconds, the 5-m Walk test assesses functional 
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capacity and performance by averaging the time that one takes to walk, with or without walking 
aids, a distance of five meters for three times.  Studies have demonstrated that the Gait Speed test 
was a valid and reliable predictor of mortality and morbidity (Afilalo et al., 2010; Green et al., 
2012; Wilson et al., 2013).  In their study, Afilalo and colleagues (2010) found that the Gait 
Speed test was “a simple and effectgive test that [might] identify a subset of vulnerable older 
adults at incrementally higher risk of mortality and major morbidity after cardiac surgery” (p. 
1668).   
3.4.4.2  Activities of Daily Living.  The ADL test (Katz et al., 1970) is one of the most 
commonly used instruments to assess one’s ability of independent daily living.  It addresses six 
functions, including bathing, dressing, toileting, transferring, continence, and feeding.  On a 
scale of zero to six, a maximum score of six indicates full function.  Lower test scores are 
indicative of greater functional impairment.  The ADL test had internal consistency with  of 
0.94 but poor test-retest reliability (Hamrin & Lindmark, 1988; Law & Letts, 1989; Shelkey & 
Wallance, 1998).  Other studies found that there was evidence of construct validity and 
predictive validity (Katz et al., 1970; Brorsson & Asberg, 1983; Wallace & Shelkey, 2008). 
3.4.4.3  Instrumental Activities of Daily Living.  The IADL test (Lawton & Brody, 1969) 
assesses independent living abilities and interactions with the physical and social environment.  
Eight domains are assessed to obtain a score that ranges from zero to eight with higher values 
indicating higher level of function and independence.  Studies have reported that the IADL had 
the reliability of internal consistency, test-retest, and inter-rater, and construct and concurrent 
validity (Kim, Won, & Cho, 2005; Graf, 2009).  
3.4.4.4  Mini Mental State Examination.  The MMSE (Folstein et al., 1975) is widely 
used for testing one’s cognitive function change.  By asking eleven questions addressing 
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different aspects of one’s mental abilities, the MMSE gives scores ranging from zero to 30, with 
lower scores indicating more severe cognitive impairment.  Tombaugh and Mclntyre (1992) 
compared the validity of the MMSE against a variety of gold standards, including Diagnostic and 
Statistical Manual of Mental Disorders.  Other studies found that the MMSE showed high levels 
of sensitivity for moderate-to-severe cognitive impairment and lower levels for mild degrees of 
impairment, and the overall validity and reliability were considered satisfactory (Vertesi et al., 
2001). 
3.4.4.5  Canadian Study of Health and Aging Clinical Frailty Scale.  In the THV 
program at the study center, the CSHA CFS (Dalhousie University Faculty of Medicine, 2012) 
was adopted to assess one’s frailty status preoperatively.  CSHA CFS scores range from one to 
nine.  Higher scores indicate greater degree of frailty status.  A five-year prospective cohort 
study of testing this scale in 2305 older adults  revealed that it was highly correlated ( = 0.80) 
with the Frailty Index.  Furthermore, statistical analyses showed that, as compared against other 
measures of cognition, function or comborbidity, the CSHA CFS performed better in predicting 
mortality (Dalhousie University Faculty of Medicine, 2012).   
Appendix C lists the functional assessment instruments used in the study center’s THV 
program.  
3.4.5  Pre-op status variables.   
3.4.5.1  New York Heart Association Classification.  The NYHA (American Heart 
Association, 2015) is commonly used in the clinical practice to assess and measure patient’s 
heart functional capacity within the past two weeks.  It is defined as a four-class and ordinal-
level variable, ranging from Class I (with cardiac disease but resulting in no limitation of 
physical activity) to Class IV (with cardiac disease resulting in inability to carry on any physical 
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activity without discomfort).  The higher class indicates worse heart functional capacity 
(American Heart Association, 2015).  Studies report that the NYHA is a reliable and valid tool 
for assessing functitional status.  It has been widely used as one of the important outcome 
comparing variables in the evaluation of TAVI procedures’ efficacy (Leon et al., 2010; Smith et 
al., 2011).  Bennett, Riegel, Bittner, and Nichols (2002) reported that the NYHA had high inter-
rater reliability and convergent validity.  
3.4.5.2  The Society of Thoracic Surgeons risk score.  According to the Society of 
Thoracic Surgeons (STS) (2014), the STS risk models “[predicted] the risk of operative mortality 
and morbidity after adult cardiac surgery on the basis of patient demographic and clinical 
variables, [and were] primarily used to adjust for case mix when comparing outcomes across 
institutions with different patient populations” (p. 1).  Higher scores indicate higher operative 
risk.  In comparison to other risk profile systems such as the European system for cardiac 
operative risk evaluation score, the STS risk score seemed to be superior and more suitable in 
assessing perioperative mortality (Wendt et al., 2009).  In the absence of a TAVI-specific risk 
score, it is important to note that the STS risk score should be used in conjunction with the expert 
team’s clinical judgments to guide clinical decision making (Piazza et al., 2010).  
3.5  Analytical Method 
To address the objectives of this study, we applied the following structured stepwise 
approach to the analysis.    
Step 1.  A retrospective chart review was first conducted to extract data from 128 
consecutive medical charts of older adults, who underwent TA TAVI procedure at the study 
center from 2010 to 2014.  A Data Collection Form (Appendix A) was developed based on 
literature reviews, previous experience and consultations of experts, and was applied by the same 
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data abstractor throughout the data collection process.  A corresponding Coding Manual 
(Appendix B) was developed and was used as a guide for ensuring consistency in data extraction 
(Gregory & Radovinsky, 2012).  The data of the 128 consecutive medical records were entered 
into an Excel file and then imported into an IBM SPSS Statistics file for statistical analyses.  
Step 2.  In SPSS, univariate descriptive statistical analyses were first performed to 
describe the distributions of the 62 independent variables as well as the dependent variable, LOS 
ordinal.  Frequencies and percentage were obtained to indicate the distributions of either 
categorical or ordinal variables whereas means, medians and standard deviations were computed 
for continuous variables.     
Step 3.  Bivariate ordinal logistic regression analyses were then performed to evaluate the 
associations of the 62 independent variables with the dependent variable, LOS ordinal, defined 
as an odds ratio.  The odds ratio is the measure that describes the strength of association between 
a predictor and the response of interest.  The Wald (2) statistics and corresponding p values 
were also calculated.  One of the purposes of obtaining the Wald (2) statistics and 
corresponding p values was to identify the variables that were thought-to-be-more-significant for 
inclusion in the multivariate ordinal logistic regression analyses.  To select variables for 
multivariate logistic regression analysis, Hosmer and Lemeshow (2000) suggested that a p value 
of 0.250 be used as a conventional cutoff.   In this study, a more stringent p value of 0.100 was 
adopted to avoid exceeding the maximum number of variables that could be included to achieve 
adequate statistical power given sample size restricitons.  Hence, for the purpose of variable 
selection, we chose the independent variables that had the Wald 2 statistics with p value equal 
or less than 0.100 and considered them more significant than those which had the Wald (2) 
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statistics of p value greater than 0.100 in terms of their impact on the length of stay after the TA 
TAVI procedure.   
Step 4.  The independent variables that met the criteria in Step 3 were included in a 
multivariate ordinal logistic regression analysis to evaluate their overall impact on the dependent 
variable, LOS ordinal.  
Step 5.  Multivariate trimming was performed to determine the independently significant 
predictors of the LOS after TA TAVI.  The details of the trimming process were as follows:   
1. The Wald 2 and corresponding p values of all the variables that had p equal or less 
than 0.100 were collectively calculated by running the multivariate ordinal logistic 
regression in SPSS.  Likelihood Ratio 2 was obtained.   
2. The variable with the smallest Wald 2 and largest p value was first removed from the 
initial variable set.  The remaining variables were then entered in the multivariate 
ordinal logistic regression for computing Wald 
2
 , corresponding p values, and 
Likelihood Ratio 2.    
3. The iterative process was repeated.  The difference between two subsequent values of 
Likelihood Ratio 2 was calculated every time when a variable was removed.   
4. At each step, the difference of Likelihood Ratio 2 was compared against the critical 
value of 2 distribution with one degree of freedom (95% CI), which is 3.841 (NIST 
Sematech, 2013).  Should the absolute value of the difference was greater than 3.841, 
the corresponding variable was then considered to have independently significant 
impact on the LOS after TA TAVI, and was therefore retained in the multivariate 
ordinal logistical regression model.  Variables that did not meet this criteria were 
excluded.   
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Step 6.  After the multivariate trimming process, a new set of variables that were deemed 
independently significant in terms of their impact on the LOS after TA TAVI remained, and 
were included again in the full multivariate ordinal logistic regression analysis to estimate their 
combined associations with the dependent variable, LOS ordinal.  
3.6  Ethical Considerations 
 The following ethical guidelines were adhered to:  1) Special measures were taken to 
protect patients’ personal identities.  In this study, the variables pertinent to patients’ personal 
identies were sex and discharge date.  Sex was one of the independent variables of interest in this 
study while discharge date was used for calculating the LOS; 2) Computerized data collection 
forms were kept by authorized study personnel in a secure location, and the collected data were 
saved on the encrypted and password protected computers of the researchers.  Furthermore, the 
data would be kept for additional five years at the end of the study, and be destroyed afterwards.  
There was no plan for future use of the data; 3) Prior to the commencement of the study, the 
Research Ethics Board (REB) approvals from Trinity Western University REB (TWU REB) and 
the University of British Columbia Providence Health Care REB (UBC PHC REB) were granted; 
and 4) the Providence Health Care Instituitional Approval was obtained.  
3.7  Chapter Summary 
 This chapter discussed the design and statistical methods of this study.  This study 
analyzed the data obtained from 128 consecutive TA TAVI medical records through a 
retrospective chart review.  Based on this study’s Predicting LOS after TA TAVI:  TA TAVI 
Surgical Process Model (Figure 1) and Predicting LOS after TA TAVI:  Conceptual Model 
(Figure 2), 62 independent variables were initially selected.  For the purpose of statistical 
analysis, three originally continuous variables, LOS, ≤72hr Blood Transfusion Units and >72hr 
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Blood Transfusion Units, were descritized to ordinal variables.  In addition, Wait Time variables 
and the instrument-type variables, including the Functional Assessment variables and risk factor 
variables unique to this study, were described.  Furthermore, the details of the statistical analyses 
used in this study were provided.  This study was approved by all relevant REBs.  In the 
following chapter, we present the results of this study.    
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Chapter Four:  Results 
 In this chapter, a sample description is first provided.  The results of univariate 
descriptive statistical analyses of the 63 variables are then discussed, followed by the results of 
the bivariate ordinal logistic regression and multivariate ordinal logistic regression analyses.  The 
selections of variables for several multivariate ordinal logistic regression analyses are illustrated 
through the multivariate trimming.  Finally, the results of multivariate ordinal logistic regression 
analyses with the variable, STS, are presented.     
4.1  Sample Description 
This study’s sample consisted of 115 medical records (N= 115) of patients who 
underwent TA TAVI procedure at the study center from 2010 to 2014, excluding eight deaths, 
three TAo
4
, and two aborted TA TAVI from the initial sample of 128 cases.   
 
Table 5 
Sample Description 
Variables (Missing) Mean (SD) Frequency (Percent) 
Age (0) 78.8 (8.7) - 
Sex (0.9%) 
      Female  - 66(57.4%)
    Male  - 48(41.7%) 
Status of Referral (7.8%) 
      Elective - 91(85.8%)
    In-patient  - 15(14.2%) 
Location of Residence (0) 
     VCH - 36(31.3%)
    FHA - 28(24.3%) 
    IHA - 23(20.0%) 
    VIHA - 17(14.8%) 
    NHA - 7(6.1%) 
    Other - 4(3.5%) 
                                                          
4
 Transaortic (TAo) is an alternative surgical access used in TAVI.  The TA and TAo approaches differ in 
peri- and post-procedure requirements.  We excluded the TAo cases from this study.   
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Home Support (35.7%) 
     None - 51(68.9%)
    Part time - 22(29.7%) 
    Full time - 1(1.4%) 
Living Situation (24.3%) 
     Lives alone/ Independent - 81(93.1%)
    Nursing home - 3(3.4%) 
    Lives with family - 3(3.4%) 
Note. N = 115.  Abbreviations.  FHA, Fraser Health Authority; IHA, Interior Health 
Authority; NHA, Northern Health Authority; VIHA, Vancouver Island Health Authority; 
VCH, Vancouver Coastal Health Authority.   
 
As shown in Table 5, the mean age of this sample was 78.8 years (SD= 8.7), with a 
relatively normally distribution (Skewness= - 0.77; Kurtosis= - 0.04, SD= 0.4).  Geographically, 
more than half of the sample came from the areas in relatively close proximity of the study 
center (the Vancouver Coastal Health Authority (VCH) (31.3%) and Fraser Health Authority 
(FHA) (24.3%)).  Prior to the TA TAVI procedure, 68.9% of the candidates did not require any 
home support services (missing 35.7%), and 93.1% lived alone or independently (missing 
24.3%).  When referred to the THV program, the majority were elective patient status (missing 
7.8%).  On average, TA TAVI patients had to wait 79.8 days (SD= 85.7) from the Date of 
Referral to the Date of Acceptance, and 107.3 days (SD= 95.1) from the Date of Acceptance to 
the date of the TA TAVI procedure.  The median total wait time was 148.0 days (SD= 141.9) 
(Figure 3).     
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Figure 3.  Distributions of Wait Time Variables
5
.  This figure illustrates the distributions of three 
Wait Time variables in this study.  N = 115.   
 
4.2  Variable Descriptions 
Univariate analyses were first conducted to provide the descriptions of the remaining 
independent variables as well as the dependent variable.   
4.2.1  Dependent variable.  As described in Section 3.4.1, the original continuous-level 
dependent variable, LOS, was converted to an ordinal-level variable, LOS ordinal.   Figure 4 
shows the comparison of the distributions of the two different levels of measurement of LOS.  
As illustrated, the distribution of the continuous-level variable, LOS, was skewed to right 
(Skewness= 3.2; Kurtosis= 11.6, SD= 0.4), while the ordinal-level variable, LOS ordinal 
demonstrated a relatively uniform distribution.  The mean and median of LOS was 11.1 days and 
7.0 days, respectively.  Most of the TA TAVI patients had a LOS less than eight days.   
                                                          
5
 Wait Time variables:  WaitTime 1:  The time period from the Date of Referral to the Date of Acceptance; 
WaitTime 2:  The time period from the Date of Acceptance to the date of TA TAVI procedure; WaitTime 
3:  The time period from the Date of Referral to the date of TA TAVI procedure, all recorded in days. 
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Figure 4.  Comparison of the Distributions of LOS Continuous vs. LOS Ordinal.  The figure 
compares the distributions of the dependent variable, LOS, before and after discretization.   
 
 
4.2.2  Pre-procedure phase variables. 
4.2.2.1  History and risk variables.  Among the 12 medical history factors selected in this 
study, the most prevalent History and Risk factor was Prior Atrial Fibrillation (45.9%), followed 
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by Prior SAVR (42.6%) and Prior Other Cardiac Surgery (41.6%).  The Prior ICD was the least 
prevalent History and Risk factor, that is, 96.4% of the sample did not have an implantable 
cardioverter defibrillator prior to the TA TAVI (Figure 5).   
 
Figure 5.  Distributions of History and Risk Variables.  This figure illustrates the distributions of 
the 12 History and Risk variables of Pre-procedure phase.  N = 115.   
 
4.2.2.2  Functional assessment variables.  The functional assessment variables consisted 
of five instruments, namely, the 5-m Gait Speed test (Mean 5-m Walk), Mini Mental State 
Examination (MMSE),  Canadian Study of Health and Aging Clinical Frailty Scale (CSHA CFS), 
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Instrumental Activities of Daily Living test (IADL), and Activities of Daily Living test (ADL), 
this study’s sample demonstrated relatively high functional capacities (Table 6).  The mean 
MMSE was 27.2/30 (SD= 2.4), indicating that overall the sample’s average cognitive function 
was within the normal range.  In addition, the results of CSHA CFS (Mean= 4.3/9; SD= 0.6), 
ADL (Mean= 5.9/6; SD= 0.5), and IADL (Mean= 6.5/8; SD= 2.0) show that this sample was 
generally vulnerable and mildly frail with moderate-to-high functioning independence.  However, 
the missing response rates of all of the seven variables were high.      
 
Table 6 
Distributions of Functional Assessment Variables 
Variables (Missing) Mean (SD) 95% CI for Mean Min Max 
Mean 5-m Walk (59.1%) 7.2 (2.8) [6.38, 8.00] 3.8 15.6 
MMSE (51.3%) 27.2 (2.4) [26.56, 27.84] 19.0 30.0 
CSHA CFS (44.3%) 4.3 (0.6) [4.18, 4.48] 3.0 6.0 
IADL (38.3%) 6.5 (1.9) [6.05, 6.97] 2.0 8.0 
ADL (37.4%) 5.9 (0.5) [5.75, 5.97] 4.0 6.0 
Note.  N = 115.  Abbreviations.  CSHA CFS, Canadian Study of Health and Aging Clinical 
Frailty Scale; ADL, Activities of Daily Living; IADL, Instrumental Activities of Daily 
Living; MMSE, Mini Mental State Examination; Mean 5-m Walk, mean 5-m Gait Speed 
test score. 
 
4.2.2.3  Pre-op status variables.  The Pre-op Status variables consisted of seven variables, 
including six continuous-level variables, LVEF, STS, BMI, Hgb, Creatinine, and eGFR, and an 
ordinal variable, NYHA.  As shown in Figure 6, NYHA Class III was 71.3%, followed by NYHA 
Class IV (22.6%), indicating that this study’s sample population was predominantly NYHA 
Class III or IV, and had marked limitations and inability of physical functions due to cardiac 
disease (AHA, 2015).  Additionally, the mean LVEF was 54.0% with a range from 20.0% to 
70.0% (missing 5.2%).  Overall, this study’s sample population had a mean BMI of 25.5 kg/m2 
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(SD= 5.9), an elevated serum creatinine level (mean= 120.3 mol/L, SD= 81.6) and a low-to-
normal hemoglobin level (mean= 121.5 g/L, SD= 16.8) preoperatively.  On average, the STS 
score was 8.7% (SD= 7.7), with a high missing response rate of 45.2%.   
 
Table 7 
Distributions of Pre-op Status Continuous Variables 
Variables (Missing) Mean (SD) 95% CI for Mean Min Max 
LVEF (5.2%) 54% (0.1) [0.51, 0.56] 20% 70% 
STS (45.2%) 8.7% (7.7) [6.78, 10.63] 1.0% 42.0% 
BMI (0) 25.5 (5.9) [24.43, 26.62] 15.2 43.7 
Hgb (0) 121.5 (16.8) [118.36, 124.56] 83.0 175.0 
Creatinine (0) 120.3 (81.6) [105.18, 135.33] 53.0 496.0 
eGFR (2.6%) 55.5 (23.6) [51.13, 59.96] 6.0 120.0 
Note.  N = 115.  Abbreviations.  LVEF, Left Ventricular Ejection Fraction; STS, the 
Society of Thoracic Surgeons risk score; BMI, Body Mass Index; Hgb, hemoglobin; 
eGFR, estimated Glomerular Filtration Rate. 
 
 
Figure 6.  Distributions of NYHA.  N = 115.   
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4.2.3  Peri-procedure phase variables.  The Peri-procedure phase variables consisted of 
three sub-group variables:  1) three Procedural Factors variables (Procedure Total Time, Valve 
Type, and Procedure Type); 2) four Peri-procedure Status variables describing the TA TAVI 
patients’ status immediately after the completion of the procedure (Airway Status, Pulmonary 
Artery Catheter, Chest Drain, and Temporary Pacemaker); and 3) nine Peri-procedure 
Complications variables pertaining to the critical care that patients received within the period of 
less than or equal to the first 72 hours of the TA TAVI.   
4.2.3.1  Procedural factors variables.  As illustrated in Figure 7, the mean total operating 
time of the TA TAVI was 103.1 minutes (SD= 3.7), with a median of 92.5 minutes and a range 
of 41.0 to 242.0 minutes (missing 0.9%).  In TAVI, as compared to native-valve procedure 
procedures, which refers to TAVI procedures pertaining to the transcatheter replacement of the 
native aortic valve, a transcatheter heart valve implantation within a failed bioprosthesis is called 
a valve-in-valve procedure.  In this study, 72.2% were native-valve procedures while 27.8% 
were valve-in-valve procedures.  In addition, the majority of TA TAVI patients had their aortic 
valves replaced (78.3%).  Only 2.6% of the TA TAVI cases involved both aortic- and mitral-
valve replacement (Figure 8).  
4.2.3.2  Peri-procedure status variables. As shown in Figure 9, prior to admission to the 
critical care unit, 26.3% of the TA TAVI patients had pulmonary artery catheter, and 17.7% had 
used temporary pacemakers.  The number of patients who were intubated was approximately 1.5 
times of those who were extubated.  Over 90.0% had chest drain inserted.   
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Figure 7.  Distribution of Procedure Total Time.  N = 114, missing 0.9%. 
 
 
 
 
 
Figure 8.  Distributions of Procedure Type and Valve Type.  This figure compares the two 
procedural variables of TA TAVI.  N = 115.     
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Figure 9.  Distributions of Peri-procedure Status Variables.  This figures illustrates the 
distributes of the four variables pertaining to TA TAVI patients’ postoperative status within the 
period of less than or equal to the first 72 hours of TA TAVI (≤72hr).  N = 115.     
 
4.2.3.3  Peri-procedure complications variables.  In this study, three common 
postoperative complications of the TA TAVI were included:  1) the variables pertaining to 
permanent pacemaker implanatation due to postoperative aberrant cardiac conductions 
(pacemaker-related variables); 2) the variables pertaining to new-onset postoperative atrial 
fibrillation (atrial fibrillation-related variables), and 3) the variables pertaining to the occurrence 
of postoperative bleeding, within and after the first 72 hours time periods (bleeding and blood 
transfusion-related variables).   
As illustrated in Figure 10, within the first 72 hours since the start time of the TA TAVI, 
there was no single case of perforation and annular dissection, three cases of cardiac arrest, and 
two cases of stroke.  Among the sample, 5.2% required permanent pacemaker implantation and 
11.3% developed new-onset atrial fibrillation shortly after the TA TAVI.  In addition, the 
occurrences of postoperative bleeding and blood transfusion were 20.0% and 22.6%, respectively, 
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indicating that these two were the most prevalent postoperative complications of the TA TAVI.  
Furthermore, 13.0% of TA TAVI patients received one-unit blood transfusion while 9.6% of 
patients received more than one unit of blood products (Figure 11).  Of the patients who received 
more than one unit of blood products through blood tranfusion, seven had two units; one had 
four units; two had five units; and one had seven units.  
4.2.4  Post-procedure phase variables.  The variables of the Post-procedure phase 
consisted of three sub-group variables:  1) one variable pertaining to the length of critical care 
(LOSICU); 2) four discharge planning related variables (Lowest Hgb, Discharge Hgb, Highest 
Creatinine, and Discharge Creatinine); and 3) eight Post-procedure Complications variables 
pertaining to postoperative complications after the first 72 hours of the TA TAVI (Table 2).   
 
 
Figure 10.  Distributions of Peri-procedure Complications Variables.  This figure illustrates the 
distributions of eight Peri-procedure Complications variables within the period of less than or 
equal to the first 72 hours of TA TAVI (≤72 hours).  N = 115.   
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Figure 11.  Distributions of ≤72hr Blood Transfusion Units.  This figure illustrates the 
distribution of blood transfusion units within the first 72 hours of TA TAVI (≤72 hours).   
N = 115.    
 
4.2.4.1  LOS in critical care variable.  The mean and median of the length of stay in the 
intensive care unit (LOSICU) was 42.0 hours and 41.5 hours, respectively (SD= 96.8), with a 
range of 18.0 to 961.0 hours (Kurtosis= 67.0, SD= 0.5) (Figure 12).          
              
 
Figure 12.  Histogram of LOSICU (hours).  This figure illustrates the distribution of the length 
of stay in the critical care. N= 114, missing 0.9%.  
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4.2.4.2  Discharge planning variables.  On average, the lowest value of hemoglobin of 
TA TAVI patients during their hospitalization was 95.8 g/L (SD= 15.1; median= 95.5 g/L), as 
compared to their mean hemoglobin level of 106.3 g/L at the time of discharge (SD= 14.5; 
median= 105.5 g/L), indicating an overall improvement in hemoglobin level.  Similarly, the 
mean highest creatinine level of TA TAVI patients during hospitalization was 147.7 mol/L 
(SD= 107.3; median= 119.0) while the average creatinine level at the time of discharge was 
121.2 mol/L (SD= 80.2; median= 99.5), showing an overall downward trending of creatinine 
level in the sample through the course of the TA TAVI (Figure 13).   
 
 
 
 
 
 
 
 
 
  
 
 
 
 
Figure 13.  Distributions of Discharge Planning Variables
6
.  This figure compares the 
distributions of the four Discharge Planning variables, including the values of hemoglobin (d/L) 
and creatinine (mol/L) during the hospitalization and upon discharge.  N=114, missing 0.9%.  
 
 
                                                          
6
 Discharge Planning variables:  In this study, Discharge Planning variables refers to the variables used in 
the discharge planning for TA TAVI patients.  Four variables were included, namely, Lowest Hgb, 
Discharge Hgb, Highest Creatinine, and Discharge Creatinine.   
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4.2.4.3  Post-procedure complications variables.  As compared to the Peri-procedure 
Complications variables, the eight Post-procedure Complications variables described the same 
perimeters of the TA TAVI patients’ care and status but in a different time period, that is, after 
the first 72 hours postoperatively until discharge.  Figure 15 illustrates the comparison between 
the two groups of variables.  As shown, during this time period, there was no single case of 
cardiac arrest or perforation, and two cases of postoperative stroke.  From the Peri-procedure 
phase to the Post-procedure phase, it is evident that there was a decreasing trend of the general 
incidence of major postoperative complications, especially the new-onset atrial fibrillation 
episodes and bleeding and blood transfusion events.  Nonetheless, when blood transfusion was 
required, most TA TAVI patients received more than one unit of blood product (4.4%), 
indicating that blood transfusion events after the first 72 hours postoperatively might be more 
significant than those within the first 72 hours time period (Figure 14).  Among the five TA 
TAVI patients who received more than one blood products, three received two units while the 
other two received five units.   
 
 
Figure 14.  Distribution of  >72hr Blood Transfusion Units.  This figure illustrates the 
distribution of the units of blood transfusion that TA TAVI patients received during the period 
from 72 hours after the procedure to the discharge (>72 hours).  N = 115. 
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Figure 1516.  Comparison of Distributions of Post-procedure Complications variables and Peri-
procedure Complications variables.  Six TA TAVI procedure related postoperative complications 
in two time periods (>72 hours vs. ≤72 hours) were compared.  N = 115.    
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4.3  Bivariate Ordinal Logistic Regression Model 
4.3.1  Results:  pre-procedure phase demographic variables.  As shown in Table 8, for 
every additional year in age, the odds of having longer LOS after the TA TAVI increased by 
1.07 times, Wald 2(1) = 10.01, p = 0.002.  All the other Demographic variables had p values 
greater than 0.100, indicating that they were not statistically significant predictors of the LOS 
and thus were excluded in the subsequent multivariate regression full model.  
 
Table 8 
Bivariate Ordinal Logistic Regression Report:  Pre-procedure Phase Demographic Variables 
Variable (Missing) 
Percent/ 
Mean (SD) OR [95% CI] Wald 2 (df) p 
 
Sex (0.9%) 
  
0.35(2) 0.839* 
            Female 57.4% 1.00 
              Male 41.7% 0.83 [0.43, 1.62] 
  
Status of Referral (7.8%) 
  
0.23(1) 0.633* 
             Elective 85.8% 1.00 
               In-patient 14.2% 1.27 [0.48, 3.38] 
  
Location of Residence (0) 
  
3.30(5) 0.653* 
             VCH 31.3% 1.00 
               FHA 24.3% 0.71 [0.29, 1.72] 
               IHA 20.0% 0.66 [0.26, 1.68] 
               VIHA 14.8% 0.72 [0.26, 2.03] 
               NHA 6.1% 0.94 [0.22, 4.01] 
               Out of Province 3.5% 0.18 [0.02, 1.34] 
  
Age (0) 78.8(8.7) 1.07 [1.03, 1.11] 10.01(1) 0.002* 
WaitTime1 (0) 79.8(85.7) 1.00 [0.99, 1.00] 0.81(1) 0.369* 
WaitTime2 (0) 107.3(95.2) 1.00 [1.00, 1.00] 0.51(1) 0.476* 
WaitTime3 (0) 187.1(141.9) 1.00 [1.00, 1.00] 0.98(1) 0.322* 
] 
Note.   
1.  N = 115. 
2.  The italicized group for each variable is the reference group for the comparison.   
3.  The odds ratio indicates to what extent the variable influences LOS relative to its reference 
group.  A ratio greater than 1.00 indicates an increase in LOS, while a ratio less than 1.00 
indicates a decrease in LOS.   
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4.  A variable's overall test of significance indicates its overall influence on LOS, expressed in 
Wald 2(df) and p value.  A bolded p value with asterisk indicates p equals 0.100 or less.  
5.  Abbreviations.  VCH, Vancouver Coastal Health Authority; VIHA, Vancouver Island Health 
Authority; FHA, Fraser Health Authority; IHA, Interior Health Authority; NHA, Northern Health 
Authority. 
 
4.3.2  Result:  pre-procedure phase history and risk variables.  The odds ratios of the 
12 History and Risk variables are presented in Table 9.  Among the 12 variables, TA TAVI 
patients who had chronic lung diseases were 2.25 times more likely to have a longer LOS than 
those who did not have such medical condition preoperatively, Wald 2(1) = 4.93, p = 0.026.  
None of the other variables had p values less than or equal to 0.100.   
 
Table 9 
Bivariate Ordinal Logistic Regression Report:  Pre-procedure Phase History and Risk Variables 
Variables (Missing) 
Percent/ 
Mean (SD) OR [95% CI] Wald 2 (df) p 
Prior PPM (1.7%) 
  
0.07 (1) 0.788* 
            No 80.5% 1.00 
              Yes 19.5% 1.12 [0.49, 2.59] 
  
Prior ICD (4.3%) 
  
0.50 (1) 0.478* 
            No 96.4 % 1.00 
              Yes 3.6% 1.92 [0.32, 11.67] 
  
Chronic Lung Disease (6.1%) 
 
4.93 (1) 0.026* 
            No 63.0% 1.00 
              Yes 37.0% 2.25 [1.10, 4.60] 
  
Diabetes (1.7%) 
  
0.51 (1) 0.474* 
            No 66.4% 1.00 
              Yes 33.6% 0.77 [0.38, 1.56] 
  
Prior Stroke (3.5%) 
  
0.69 (1) 0.405* 
            No 80.2% 1.00 
              Yes 19.8% 1.43 [0.62, 3.31] 
  
Prior MI (7.8%) 
  
0.00 (1) 0.982* 
            No 69.8% 1.00 
              Yes 30.2% 1.01 [0.48, 2.12] 
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Prior Atrial Fibrillation (3.5%) 
 
2.09 (1) 0.149* 
            No 54.1% 1.00 
              Yes 45.9% 1.64 [0.84, 3.23] 
  
Prior Other Cardiac Surgery (1.7%) 0.76 (1) 0.383* 
            No 58.4% 1.00 
              Yes 41.6% 0.74 [0.38, 1.45] 
  
Prior CABG (0.9%) 
  
0.49 (1) 0.486* 
            No 62.3% 1.00 
              Yes 37.7% 0.79 [0.40, 1.55] 
  
Prior PCI (1.7%) 
  
0.22 (1) 0.643* 
            No 69.0% 1.00 
              Yes 31.0% 1.19 [0.58, 2.42] 
  
Prior SAVR (0) 
  
1.61 (1) 0.204* 
            No 57.4% 1.00 
              Yes 42.6% 0.65 [0.33, 1.26] 
  
Prior BAV (0) 
  
0.05 (1) 0.832* 
            No 91.3% 1.00 
              Yes 8.7% 1.13 [0.36, 3.63] 
  Note.   
1.  N = 115. 
2.  The italicized group for each variable is the reference group for the comparison.   
3.  The odds ratio indicates to what extent the variable influences LOS relative to its reference 
group.  A ratio greater than 1.00 indicates an increase in LOS, while a ratio less than 1.00 
indicates a decrease in LOS.   
4.  A variable's overall test of significance indicates its overall influence on LOS, expressed in 
Wald 2(df) and p value.  A bolded p value with asterisk indicates p equals 0.100 or less.  
5.  Abbreviations.  PPM, permanent pacemaker; ICD, implantable cardioverter defibrillator; MI, 
myocardial infarction; CABG, coronary artery bypass surgery; PCI, percutaneous coronary 
intervention; SAVR, SAVR; BAV, balloon aortic valvuloplasty. 
 
4.3.3  Results:  pre-procedure phase functional assessment variables.  Table 10 
presents the results of these variables.  The two social and environmental variables were Home 
Support and Living Situation, neither of which was statistically significantly associated with the 
LOS.  Likewise, none of the functional assessment variables had p values less than 0.05, 
indicating that these variables were not statistically significant predictors of LOS after TA TAVI.  
For instance, the odds ratios of CSHA CFS and ADL were 1.59 and 1.54, with p = 0.230 and 
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0.364, respectively.  It should be noted, however, that all of the seven functional assessment 
variables had relatively high missing response rates, which might have influenced the 
significance of their associations with the LOS.  Nonetheless, none of the variables from this 
category was selected into the subsequent multivariate regression full model due to their p values, 
which were all greater than 0.100.    
 
Table 10 
Bivariate Ordinal Logistic Regression Report:  Pre-procedure Phase Functional Assessment 
Variables 
Variables (Missing) 
Percent/ 
Mean (SD) OR [95% CI] Wald 2 (df) p 
Home Support (35.7%) 
  
1.24 (2) 0.539* 
            None 68.9% 1.00 
              Full Time 1.4% 2.68 [0.07, 97.12] 
              Part Time 29.7% 1.59 [0.65, 3.93] 
  
Living Situation (24.3%) 
  
2.95 (2) 0.229* 
            Lives alone/ Independent 93.1% 1.00 
              Nursing home 3.4% 2.49 [0.31, 20.39] 
              Lives with Family 3.4% 5.99 [0.60, 59.86] 
  
CSHA CFS (44.3%) 4.3 (0.6) 1.59 [0.75, 3.39] 1.44 (1) 0.230* 
ADL (37.4%) 5.9 (0.5) 1.54 [0.60, 3.95] 0.82 (1) 0.364* 
IADL (38.3%) 6.5 (1.9) 0.93 [0.75, 1.16] 0.38 (1) 0.537* 
MMSE (51.3%) 27.2 (2.4) 1.01 [0.82, 1.23] 0.00 (1) 0.964* 
Mean 5-m Walk (59.1%) 7.2 (2.8) 1.02 [0.85, 1.23] 0.05 (1) 0.830* 
Note.   
1.  N = 115. 
2.  The italicized group for each variable is the reference group for the comparison.   
3.  The odds ratio indicates to what extent the variable influences LOS relative to its reference 
group.  A ratio greater than 1.00 indicates an increase in LOS, while a ratio less than 1.00 
indicates a decrease in LOS.   
4.  A variable's overall test of significance indicates its overall influence on LOS, expressed in 
Wald 2(df) and p value.  A bolded p value with asterisk indicates p equals 0.100 or less.  
5.  Abbreviations.  CSHA CFS, Canadian Study of Health and Aging Clinical Frailty Scale; ADL, 
Activities of Daily Living; IADL, Instrumental Activities of Daily Living; MMSE, Mini Mental 
State Examination; Mean 5-m Walk, mean 5-m Gait Speed test.   
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4.3.4  Results:  pre-procedure phase pre-op status variables.  As illustrated in Table 
11, under this category, the variables that met the study’s selection criteria for the multivariate 
regression full model (p ≤ 0.100) included STS, BMI, and Hgb.  Despite the high missing 
response rate, the variable of STS had an odds ratio of 1.08, indicating that a relative increase in 
STS was associated with increased odds of having longer LOS, Wald 2 (1) = 4.57, p = 0.033.  
The mean BMI was 25.5 (SD= 5.9).  The odds ratio of BMI (OR= 0.95) indicated that for every 
unit of increase in BMI value, the odds ratio of having longer LOS decreased 0.95 times, Wald 
2 (1) = 3.58 (1), p = 0.058.  Similarly, the preoperative baseline hemoglobin level of TA TAVI 
patients seemed to play a relatively significant role in influencing the LOS (OR = 0.98, Wald 2 
(1) = 4.47, p = 0.034).   
The TA TAVI population was predominantly NYHA Class III and IV (93.9%).  As 
shown in Table 11, the NYHA classification was  not statistically signficiantly associated with 
the LOS (Wald 2 (3) = 0.49, p = 0.921).  Similarly, neither the preoperative baseline creatinine 
level nor eGFR level was statistically significantly associated with having longer LOS (OR = 
1.00 and 0.99, p = 0.781 and 0.202, respectively).   
 
Table 11 
Bivariate Ordinal Logistic Regression Report: Pre-procedure Phase Pre-op Status Variables 
Variables (Missing) 
Percent/ 
Mean (SD) OR [95% CI] Wald 2 (df) p 
NYHA (0) 
  
0.49 (3) 0.921* 
            Class III 71.3% 1.00 
              Class I 0.9 % 2.09 [0.06, 74.67] 
              Class II 5.2% 0.90 [0.20, 3.97] 
              Class IV 22.6% 1.25 [0.57, 2.75] 
  
STS (45.2%) 8.7% (7.7) 1.08 [1.01, 1.16] 4.57 (1) 0.033* 
LVEF (5.2%) 54% (0.1) 0.51 [0.05, 5.57] 0.30 (1) 0.583* 
BMI (0) 25.5 (5.9) 0.95 [0.89, 1.00] 3.58 (1) 0.058* 
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Hgb (0) 121.5 (16.8) 0.98 [0.96, 1.00] 4.47 (1) 0.034* 
Creatinine (0) 120.3 (81.6) 1.00 [1.00, 1.00] 0.08 (1) 0.781* 
eGFR (2.6%) 55.5 (23.6) 0.99 [0.98, 1.01] 1.63 (1) 0.202* 
Note.   
1.  N = 115. 
2.  The italicized group for each variable is the reference group for the comparison.   
3.  The odds ratio indicates to what extent the variable influences LOS relative to its reference 
group.  A ratio greater than 1.00 indicates an increase in LOS, while a ratio less than 1.00 
indicates a decrease in LOS.   
4.  A variable's overall test of significance indicates its overall influence on LOS, expressed in 
Wald 2(df) and p value.  A bolded p value with asterisk indicates p equals 0.100 or less.  
5.  Abbreviations.  NYHA, New York Heart Association Functional Classification; LVEF, Left 
Ventricular Ejection Fraction; STS, the Society of Thoracic Surgeons Risk score; BMI, Body 
Mass Index; Hgb, hemoglobin; eGFR, estimated Glomerular Filtration Rate. 
 
4.3.5  Results:  peri-procedure phase variables.  Table 12 presents the odds ratios of 
the 16 Peri-procedure phase variables.  Within the first 72 hours of the TA TAVI surgical 
process, seven variables, namely, Procedure Total Time, Procedure Type, Chest Drain, 
Temporary Pacemaker, ≤72hr Bleed, ≤72hr Blood Transfusion, and ≤72hr Blood Transfusion 
Units, were statistically significantly associated with the LOS.  The odds ratio of Procedure 
Total Time is 1.01, meaning that longer total operating time of the TA TAVI was associated with 
increased odds of 1.01 times in having longer LOS postoperatively (Wald 2 (1) = 4.74, p = 
0.029).  Similarly, patients who had the valve-in-valve TA TAVI had decreased odds of having 
longer LOS by 0.46 times (Wald 2 (1) = 4.11, p = 0.043), as compared to those who had native-
valve TA TAVI.  In addition, the use of chest drain and temporary pacemaker at the completion 
of the TA TAVI were associated with increased odds of having longer LOS, though the latter 
was not statistically significant (OR = 5.15 and 2.37, p = 0.018 and 0.055, respectively).  
Moreover, the three bleeding and blood transfusion related variables were significantly 
associated with LOS after TA TAVI.   
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Table 12 
Bivariate Ordinal Logistic Regression Report:  Peri-procedure Phase Variables 
Variables 
Percent/ 
Mean (SD) OR [95% CI] Wald 2 (df) p 
Valve Type (0) 
  
2.17 (2) 0.339* 
            Aortic Valve 78.3% 1.00
              Both 2.6% 1.29 [0.16, 10.16] 
              Mitral Valve 19.1% 0.54 [0.23, 1.26] 
  
Procedure Type (0) 
  
4.11 (1) 0.043* 
             Native Valve 72.2% 1.00 
               Valve-in-valve 27.8% 0.46 [0.22, 0.98] 
  
Airway Status: Intubated (0.9%) 
  
0.96 (1) 0.326* 
             No 41.2% 1.00 
               Yes 58.8% 1.40 [0.72, 2.74] 
  
Pulmonary Artery Catheter (0.9%) 
  
0.00 (1) 0.984* 
             No 73.7% 1.00 
               Yes 26.3% 1.01 [0.48, 2.13] 
  
Chest Drain (2.6%) 
  
5.55 (1) 0.018* 
             No 8.0% 1.00 
               Yes 92.0% 5.15 [1.32, 20.12] 
  
Temporary Pacemaker (1.7%) 
  
3.67 (1) 0.055* 
             No 82.3% 1.00 
               Yes 17.7% 2.37 [0.98, 5.74] 
  
≤72hr Pacemaker (0) 
  
0.02 (1) 0.880* 
             No 94.8% 1.00 
               Yes 5.2% 1.12 [0.26, 4.89] 
  
≤72hr Atrial Fibrillation (0) 
  
0.04 (1) 0.846* 
             No 88.7% 1.00 
               Yes 11.3% 0.90 [0.32, 2.54] 
  
≤72hr Stroke (0) 
  
1.29 (1) 0.257* 
             No 98.3% 1.00 
               Yes 1.7% 4.95 [0.31, 78.37] 
  
≤72hr Perforation (0) 
  
- - 
             No 100.0%
                Yes 0 
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≤72hr Annular Dissection (0) 
  
- - 
             No 100.0%
                Yes 0 
   
≤72hr Cardiac Arrest (0) 
  
0.62 (1) 0.430* 
             No 97.4% 1.00 
               Yes 2.6% 2.33 [0.29, 18.91] 
  
≤72hr Bleed (0) 
  
11.36 (1) 0.001* 
             No 80.0% 1.00 
               Yes 20.0% 4.51 [1.88, 10.82] 
  
≤72hr Blood Transfusion (0) 
  
10.23(1) 0.001* 
             No 77.4% 1.00 
               Yes 22.6% 3.85 [1.69, 8.80] 
  
≤72hr Blood Transfusion Units (0) 
  
10.50 (2) 0.005* 
             No 77.4% 1.00 
               1 unit 13.0% 4.68 [1.65, 13.33] 
               More than 1 unit 9.6% 2.98 [0.95, 9.42] 
  
Procedure Total Time (0.9%) 103.1 (39.7) 1.01 [1.00, 1.02] 4.74 (1) 0.029* 
Note.   
1.  N = 115. 
2.  The italicized group for each variable is the reference group for the comparison.   
3.  The odds ratio indicates to what extent the variable influences LOS relative to its reference 
group.  A ratio greater than 1.00 indicates an increase in LOS, while a ratio less than 1.00 
indicates a decrease in LOS.   
4.  A variable's overall test of significance indicates its overall influence on LOS, expressed in 
Wald 2(df) and p value.  A bolded p value with asterisk indicates p equals 0.100 or less.  
5.  Abbreviation.  ≤72hr, less than or equal to the first 72 hours after TA TAVI  procedure. 
 
4.3.6  Results:  post-procedure phase variables.  The 13 variables included in the Post-
procedure phase are focused on the length of stay in the critical care, patients’ postoperative 
complications after the first 72 hours until the time of discharge, and discharge planning.  Table 
13 presents the 13 variables’ odds ratios and their corresponding p values.   
As shown in Table 13, during this time period, seven variables, including LOSICU, 
Lowest Hgb, Discharge Hgb, Highest Creatinine, >72hr Bleed, >72hr  Blood Transfusion, 
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and >72hr Blood Transfusion Units, seemed to be statistically significantly associated with the 
LOS.  Specifically, LOSICU had an odds ratio of 1.03, indicating that every hour of increase in 
the total stay of the critical care was associated with an increase of 1.03 time in having longer 
LOS postoperatively (Wald 2 (1) = 17.27, p = 0.000).  Likewise, for every unit of increase in 
the baseline hemoglobin level during hospitalization and hemoglobin level upon discharge, the 
likelihood of having longer LOS decreased by 0.96 and 0.98 times, respectively, though the latter 
was not statistically significant (Wald 2 (1) = 12.13 and 3.49, p = 0.000 and 0.062).  Despite an 
odds ratio of 1.00, Highest Creatinine was also significantly associated with LOS (p = 0.042)   
Furthermore, similar to the other three corresponding bleeding and blood transfusion 
related variables within the first 72 hours of the TA TAVI surgical process, the bleeding and 
blood transfusion occurrences in this time period were associated with the LOS, with p values all 
less than 0.100.     
 
Table 13 
Bivariate Ordinal Logistic Regression Report:  Post-procedure Phase Variables 
Variables (Missing) 
Percent/ 
Mean (SD) OR [95% CI] Wald 2 (df) p 
>72hr Pacemaker (0) 
  
1.99 (1) 0.158* 
             No 94.8% 1.00 
               Yes 5.2% 3.00 [0.65, 13.80] 
  
>72hr Atrial Fibrillation (0) 
  
1.84 (1) 0.175* 
             No 91.3% 1.00 
               Yes 8.7% 2.27 [0.70, 7.41] 
  
>72hr Stroke (0) 
  
0.00 (1) 0.999* 
             No 98.3% 1.00 
               Yes 1.7% - 
  
>72hr Perforation (0)  
  
- - 
             No 100.0% - 
               Yes 0 - 
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>72hr Cardiac Arrest (0)  
  
- - 
             No 100.0% - 
               Yes 0 - 
  
>72hr Bleed (0.9%) 
  
7.74 (1) 0.005* 
             No 93.9% 1.00 
               Yes 6.1% 11.81 [2.07, 67.22] 
  
>72hr Blood Transfusion (0.9%) 
  
5.16 (1) 0.023* 
             No 93.9% 1.00 
               Yes 6.1% 5.84 [1.27, 26.76] 
  
>72hr Blood Transfusion Units (0.9%) 
  
5.16 (2) 0.076* 
             No 93.9% 1.00 
               1 unit 1.8% 5.66 [0.36, 89.52] 
               More than 1 unit 4.4% 5.92 [0.99, 35.39] 
  
LOSICU (0.9%) 62.0 (96.8) 1.03 [1.01, 1.04] 17.27 (1) 0.000* 
Lowest Hgb (0.9%) 95.8 (15.1) 0.96 [0.94, 0.98] 12.13 (1) 0.000* 
Discharge Hgb (0.9%) 106.3(14.5) 0.98 [0.96, 1.00] 3.49 (1) 0.062* 
Highest Creatinine (0.9%) 147.7 (107.3) 1.00 [1.00, 1.01] 4.13 (1) 0.042* 
Discharge Creatinine (0.9%) 121.2 (80.2) 1.00 [1.00, 1.01] 1.30 (1) 0.255* 
Note.   
1.  N = 115. 
2.  The italicized group for each variable is the reference group for the comparison.   
3.  The odds ratio indicates to what extent the variable influences LOS relative to its reference 
group.  A ratio greater than 1.00 indicates an increase in LOS, while a ratio less than 1.00 
indicates a decrease in LOS.   
4.  A variable's overall test of significance indicates its overall influence on LOS, expressed in 
Wald 2(df) and p value.  A bolded p value with asterisk indicates p equals 0.100 or less.  
5.  Abbreviations.  Hgb, hemoglobin; eGFR, estimated Glomerular Filtration Rate; >72hr, more 
than 72 hours after TA TAVI. 
 
4.4  Independent Variables with p ≤ 0.100 
As discussed in Chapter 3, in this study, variables that had p value equal or less than 
0.100 from the bivariate ordinal logistic regression analyses were considered potentially 
significant and would therefore be included in the multivariate ordinal logistic regression model 
(Hosmer & Lemeshow, 2000).  According to the findings above, 19 out of 62 independent 
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variables had met this requirement.  Although the variable of STS also met this criterion, it was 
excluded because of its high percentage of missing responses (45.2%).  As a result, 18 
independent variables (Table 14) were selected into the multivariate ordinal logistic regression 
analysis that follows.   
 
Table 14 
18 Independent Variables with p≤ 0.10 by Procedure Phases 
Pre-Procedure Phase Peri-Procedure Phase Post-Procedure Phase 
Age Procedure Total Time LOSICU 
Chronic Lung Disease Procedure Type >72hr Bleed 
BMI Chest Drain >72hr Blood Transfusion 
Hgb Temporary Pacemaker >72hr Blood Transfusion Units 
 
≤72hr Bleed Lowest Hgb 
 
≤72hr Blood Transfusion Discharge Hgb 
 
≤72hr Blood Transfusion Units Highest Creatinine 
Note.  Dependent Variable:  LOS ordinal.  Abbreviations.  LOSICU, length of stay in 
critical care; BMI, Body Mass Index; Hgb, hemoglobin;  ≤72hr, less than or equal to the 
first 72 hours after TA TAVI ;  >72hr, more than 72 hours after TA TAVI. 
 
4.5  Multivariate Ordinal Logistic Regression Model:  Full Model 
4.5.1  Full model:  assumptions.  Statistics were first conducted to test the 18-variable 
model’s multicollinearity and goodness of fit.  In Table 15, multicollinearity statistics show that, 
when eighteen variables were included, the variables pertaining to blood transfusion and blood 
transfusion units had Variance Inflation Factor (VIF) values of ten or greater.  It is not surprising 
that these variables were highly correlated considering that they all pertained to the occurrence of 
a blood transfusion.  A decision was then made to retain only one of the blood transfusion 
variables.  After removing the three variables that had VIF greater than ten, namely, ≤72hr Blood 
Transfusion, >72hr Blood Transfusion, and >72hr Blood Transfusion Units, the remaining 
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fifteen variables had the VIF values that were less than ten (Table 15).  Table 16 presents the 15 
independent variables with p value equal or less than 0.100 that were finally selected in the 
multivariate ordinal logistic regression model.       
 
Table 15 
Full Model Multi-collinearity Test:  18 Variables vs. 15 Variables 
 
Collinearity Statistics 
18 Variables 
Collinearity Statistics 
14 Variables 
Independent Variables VIF VIF 
>72hr Blood Transfusion 23.38 ─ 
>72hr Blood Transfusion Units 16.90 ─ 
≤72hr Blood Transfusion 13.33 ─ 
≤72hr Blood Transfusion Units 9.12 2.75 
>72hr Bleed 8.28 1.55 
Lowest Hgb 4.70 4.40 
≤72hr Bleed 4.60 2.92 
Discharge Hgb 4.22 3.83 
Hgb 2.40 2.26 
LOSICU 1.77 1.55 
BMI 1.35 1.33 
Age 1.34 1.33 
Procedure Total Time 1.23 1.15 
Chronic Lung Disease 1.21 1.16 
Temporary Pacemaker 1.18 1.13 
Highest Creatinine 1.15 1.15 
Procedure Type 1.14 1.14 
Chest Drain 1.13 1.12 
Note.  Dependent Variable: LOS ordinal.  Abbreviations.  LOSICU, length of stay in 
intensive care unit; BMI, Body Mass Index; Hgb, hemoglobin;  ≤72hr, less than or equal to 
the first 72 hours after TA TAVI ;  >72hr, more than 72 hours after TA TAVI. 
 
Predicting the LOS After TA TAVI 68 
 
Table 16 
List of 15 Independent Variables of Full Model 
Pre-procedure Phase Peri-procedure Phase Post-procedure Phase 
 
Age Procedure Total Time LOSICU 
 
Chronic Lung Disease Procedure Type >72hr Bleed 
 
BMI Chest Drain Lowest Hgb 
 
Hgb Temporary Pacemaker Discharge Hgb 
  
≤72hr Bleed Highest Creatinine 
   
≤72hr Blood Transfusion Units 
 
Note. Dependent Variable:  LOS ordinal.  Abbreviation.  LOSICU, length of stay in critical 
care; BMI, Body Mass Index; Hgb, hemoglobin;  ≤72hr, less than or equal to the first 72 
hours after TA TAVI ;  >72hr, greater than 72 hours after TA TAVI. 
 
In addition, as assessed by a full likelihood ratio test comparing the residual of the fitted 
location model to a model with varying location parameters, 2 (32) = 129.7, p = 0.000, the 
assumption of proportional odds was not met.  To further investigate the assumption of 
proportional odds, separate binomial logistic regression analyses were run by recoding the 
dependent variable, LOS ordinal, into three dichotomised cumulative categories, named as LOS 
Ordinal Category 1 (LOS more than 12 days), LOS Ordinal Category 2 (LOS more than 7 days), 
and LOS Ordinal Category 3 (LOS more than 5 days).  These three dichotomous dependent 
variables represented the cumulative splits of the four categories of the ordinal dependent 
variable, LOS ordinal, and were necessary for establishing the viability of the assumption of 
proportional odds.   
Table 17 shows the results of the separate bionomial logistic regression statistics.  As 
shown, the proportional odds assumption might be met, depending on the variables.  For instance, 
the odds ratios of the variable of pre-operative baseline hemoglobin level were similar (OR= 
0.99, 1.00, and 0.98, respectively), indicating that, for this variable, the assumption of 
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proportional odds appeared tenable.  On the other hand, several variables had different odds 
ratios to varying degrees.  For example, considering the variable of ≤72 Blood Transfusion Units 
More than 1 unit, the odds ratios for LOS Ordinal Category 2 and 3 were similar, but different 
from the odds ratio for LOS ordinal Category 1, indicating that, for this variable, the assumption 
of similar odds might not be tenable and thus required caution in the interpretation of the final 
ordinal regression model. 
4.5.2  Full model:  goodness of fit.  The Deviance goodness-of-fit test indicates that the 
model was a good fit to the 15-variable dataset (2 (287) = 222.2, p = 0.998).  In addition, the 
Pearson goodness-of-fit test supports that the model was a good fit (2 (287) = 298.4, p = 0.309).  
However, when interpreting these two measures, caution should be given to the fact that there 
were 306 (75%) cells with zero frequencies.  Nonetheless, the final model statistically 
significantly predicts the dependent variable, LOS ordinal, over and above the intercept-only 
model (2 (16) = 56.1, p = 0.000), indicating that the goodness of fit was met in this model.  
Moreover, the pseudo R-square tests reports a Cox and Snell of 0.42 and Nagelkerke of 0.45, 
both supporting the goodness of fit requirement.   
 
Table 17 
Full Model Proportional Odds:  Variables in the Equation 
 
B (parameter estimates) Exp(B) (Odds Ratio) 
Independent  
Variable 
LOS  
Ordinal 
Category 1 
LOS  
Ordinal 
Category 2 
LOS  
Ordinal 
Category 3 
LOS  
Ordinal 
Category 1 
LOS  
Ordinal 
Category 2 
LOS  
Ordinal 
Category 3 
Age 0.13 0.08 0.01 1.14 1.08 1.01 
BMI 0.05 -0.03 -0.05 1.05 0.97 0.95 
Hgb -0.01 0.00 -0.02 0.99 1.00 0.98 
Procedure Total 
Time 
-0.01 0.00 0.02 0.99 1.00 1.03 
LOSICU 0.02 0.03 0.05 1.02 1.03 1.05 
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Lowest Hgb -0.02 -0.03 -0.04 0.98 0.97 0.96 
Discharge Hgb -0.05 0.00 0.03 0.96 1.00 1.03 
Highest 
Creatinine 
0.00 0.00 0.00 1.00 1.00 1.00 
≤72hr Blood 
TransfusionUnits  
(>1 unit) 
1.29 -0.50 -0.78 3.63 0.60 0.46 
≤72hr Blood 
TransfusionUnits 
(1 unit) 
-0.24 0.57 -0.22 0.79 1.76 0.80 
Chronic Lung 
Disease 
2.52 1.19 0.52 12.40 3.29 1.69 
Procedure Type -2.02 -1.25 0.71 0.13 0.29 2.03 
Chest Drain -2.65 -0.68 2.52 0.07 0.51 12.44 
Temporary 
Pacemaker 
2.02 2.60 1.13 7.50 13.49 3.11 
≤72hr Bleed 1.01 0.32 0.53 2.74 1.38 1.71 
>72hr Bleed 0.67 18.88 17.13 1.96 1.58108 2.74107 
Constant -4.59 -5.31 -3.51 0.01 0.00 0.03 
 
4.5.3  Full model:  results.  Fifteen independent variables were included in the 
multivariate ordinal logistic regression full model to compute their odds ratios in association 
with, and estimate their effect on, the dependent variable, LOS ordinal. A p value equal or less 
than 0.050 was considered significant.    
As illustrated in Table 18, the sample size was 102, and the overall missing response rate 
was 11.3 %.  Over 50 % of the sample had a LOS of less than eight days.  Among the 15 
independent variables, three variables, Chronic Lung Disease, Temporary Pacemaker, and 
LOSICU, had statistically significant overall effect on the LOS (p = 0.013, 0.022, and 0.002, 
respectively).  Specifically, the incidences of chronic lung disease and temporary pacemaker use 
Predicting the LOS After TA TAVI 71 
at the completion of the TA TAVI procedure were associated with increased odds in having 
longer LOS by 2.96 and 3.67 times, respectively, both with statistically significant overall effects 
(Wald 2(1) = 6.16 and 5.25, p = 0.013 and 0.022, respectively).  In addition, every additional 
hour that TA TAVI patient spent in the critical care increased the likelihood of having longer 
LOS by 1.02 times (Wald 2(1) = 9.62, p = 0.002).    
In conclusion, 18 independent variables were first identified to have p equal or less than 
0.100, which were computed from the bivariate ordinal logistic regression.  After the tests for the 
assumptions, only 15 of them remained and were selected in the multivariate ordinal logistic 
regression full model.  With the 15-variable dataset, the full model had no multi-collinearity 
issue and showed goodness of fit to this study’s dataset.  The assumption of proportional odds 
appeared to be tenable.  Finally, according to the results of the full model, among the 15 
variables, three variables, including Chronic Lung Disease, Temporary Pacemaker, and LOSICU, 
demonstrated a statistically significant effect on the LOS after TA TAVI.  
 
Table 18 
Report of Multivariate Ordinal Logistic Regression Full Model: 15-variable Dataset 
 
Percent/ 
Mean (SD) OR [95% CI] Wald 2 (df) p 
Dependent Variable 
    LOS ordinal 
                Less than 6 days 24.5% 
               6 - 7 days 32.4% 
               8 - 12 days 17.6% 
               More than 12 days 25.5% 
   
Independent Variables 
    Chronic Lung Disease 
  
6.16 (1) 0.013* 
             No 62.7% 1 
               Yes 37.3% 2.96 [1.26, 6.98] 
  
Procedure Type 
  
0.69 (1) 0.408* 
             Native Valve 71.6% 1 
               Valve in valve 28.4% 0.68 [0.27, 1.70] 
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Chest Drain  
  
1.21 (1) 0.272* 
             No 5.9% 1 
               Yes 94.1% 2.64 [0.47, 14.95] 
  
Temporary Pacemaker  
  
5.25 (1) 0.022* 
             No 83.3% 1 
               Yes 16.7% 3.67 [1.21, 11.18] 
  
≤72hr Bleed 
  
0.06 (1) 0.800* 
             No 81.4% 1 
               Yes 18.6% 0.77 [0.10, 5.87] 
  
≤72hr Blood Transfusion Units  
  
1.00 (2) 0.606* 
             No 78.4% 1 
               More than 1 unit 7.8% 1.33 [0.17, 10.30] 
               1 unit 13.7% 2.71 [0.34, 21.45] 
  
>72hr Bleed 
  
0.52 (1) 0.471* 
             No 93.1% 1 
               Yes 6.9% 2.28 [0.24, 21.29] 
  
Age  78.7 (8.5) 1.04 [0.99, 1.10] 2.14 (1) 0.144* 
BMI  25.5 (6.1) 0.99 [0.92, 1.06] 0.09 (1) 0.765* 
Hgb  121.0 (17.0) 1.00 [0.96, 1.03] 0.09 (1) 0.761* 
Procedure Total Time  103.5 (39.9) 1.01 [1.00, 1.02] 1.17 (1) 0.280* 
LOSICU  61.7 (101.4) 1.02 [1.01, 1.04] 9.66 (1) 0.002* 
Lowest Hgb  95.8 (15.1) 0.98 [0.93, 1.03] 0.67 (1) 0.414* 
Discharge Hgb 106.9 (14.7) 1.00 [0.95, 1.05] 0.01 (1) 0.935* 
Highest Creatinine  150.0 (112.0) 1.00 [1.00, 1.01] 1.20 (1) 0.274* 
Note.   
1.  N = 102.  Missing 11.3%. 
2.  The italicized group for each variable is the reference group for the comparison.   
3.  The odds ratio indicates to what extent the variable influences LOS relative to its reference 
group.  A ratio greater than 1.00 indicates an increase in LOS, while a ratio less than 1.00 
indicates a decrease in LOS.   
4.  A variable's overall test of significance indicates its overall influence on LOS, expressed in 
Wald 2(df), p value.  A bolded p value with asterisk indicates p equals 0.050 or less. 
5. Abbreviations.  LOSICU, length of stay in critical care; BMI, Body Mass Index; Hgb, 
hemoglobin;  ≤72hr, less than or equal to the first 72 hours after TA TAVI ;  >72hr, more than 
72 hours after TA TAVI. 
Predicting the LOS After TA TAVI 73 
4.6  Full Model Multivariate Trimming   
To identify the subset of the variables that were independently significant predictors of 
the LOS after TA TAVI from the 15-variable dataset, we performed the multivariate trimming.  
In the following sections, the results of multivariate trimming process are discussed and 
presented.   
4.6.1  Results.  Table 19 shows the initial values of Wald 2 of the 15-variable dataset in 
the order of smallest to largest as well as their corresponding p values, which were obtained from 
the statistics of Tests of Model Effects in the full model.  The computation suggested that the 
variable of Discharge Hgb had the smallest Wald 2 and the largest p values among this dataset 
(Wald 2(1) = 0.01, p = 0.935).  Hence, the variable of Discharge Hgb was first removed.  The 
Likelihood Ratio 2 was then obtained for the remaining fourteen-variable dataset and compared 
with that of the initial 15-variable dataset, and difference was calculated.  While comparing to 
the critical value of  2 with one degree of freedom (3.841), the first difference of 0.000 from 
removing Discharge Hgb indicated that the change in 2 from the 15-variable dataset to the 
fourteen-variable dataset was insignificant, suggesting that the variable of Discharge Hgb be 
excluded.  
Table 20 further illustrates this iterative process.  After the variable of Discharge Hgb 
was removed, the Wald 2 and p values of the remaining fourteen-variable dataset were re-
calculated.  As shown, the variable of ≤72 Bleed became the next one to be trimmed in the model 
because of its largest p value and smallest Wald 2 (Wald 2(1) = 0.06, p = 0.801) in this 
computation.  
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Table 19 
Report of Test of Model Effects on 15-variable Full Model 
 
Wald 2 df p 
Discharge Hgb 0.01 1 0.935* 
≤72hr Bleed 0.06 1 0.800* 
BMI  0.09 1 0.765* 
Hgb  0.09 1 0.761* 
>72hr Bleed 0.52 1 0.471* 
Lowest Hgb  0.67 1 0.414* 
Procedure Type 0.69 1 0.408* 
≤72hr Blood Transfusion Units  1.00 1 0.606* 
Procedure Total Time  1.17 1 0.280* 
Highest Creatinine  1.20 1 0.274* 
Chest Drain  1.21 1 0.272* 
Age  2.14 1 0.144* 
Temporary Pacemaker  5.25 1 0.022* 
Chronic Lung Disease 6.16 1 0.013* 
LOSICU  9.66 1 0.002* 
Note.   
1.  N = 102.  Missing 11.3%. 
2.  A variable's overall test of significance indicates its overall influence on LOS, 
expressed in Wald 2(df),  p value.  A bolded p value with asterisk indicates p equals 
0.050 or less. 
3. Abbreviations.  LOSICU, length of stay in critical care; BMI, Body Mass Index; Hgb, 
hemoglobin;  ≤72hr, less than or equal to the first 72 hours after TA TAVI ;  >72hr, 
more than 72 hours after TA TAVI. 
 
Table 20 
Report of Test of Model Effects on 14-variable Dataset of Full Model:   
Removing Discharge Hgb 
 
Wald 2 df p 
≤72hr Bleed 0.06 1 0.801* 
BMI  0.09 1 0.767* 
Hgb  0.09 1 0.761* 
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>72hr Bleed 0.53 1 0.469* 
Procedure Type 0.69 1 0.408* 
≤72hr Blood Transfusion Units  1.00 2 0.606* 
Lowest Hgb  1.15 1 0.284* 
Procedure Total Time  1.17 1 0.280* 
Highest Creatinine  1.20 1 0.273* 
Chest Drain  1.21 1 0.272* 
Age  2.21 1 0.137* 
Temporary Pacemaker  5.25 1 0.022* 
Chronic Lung Disease 6.16 1 0.013* 
LOSICU  9.76 1 0.002* 
Note.   
1.  N = 102.  Missing 11.3%. 
2.  A variable's overall test of significance indicates its overall influence on LOS, 
expressed in Wald 2(df),  p value.  A bolded p value with asterisk indicates p equals 
0.050 or less. 
3. Abbreviations.  LOSICU, length of stay in critical care; BMI, Body Mass Index; Hgb, 
hemoglobin;  ≤72hr, less than or equal to the first 72 hours after TA TAVI ;  >72hr, 
more than 72 hours after TA TAVI. 
 
Following this approach, the 15 variables were being trimmed one after another.  To 
reiterate, the trimming process started with removing the variable of Discharge Hgb.  The 
difference between the two Likelihood Ratio 2 values was 0.00, which was computed from 
subtracting 56.09 of the 15-variable dataset from 56.09 of the fourteen-variable dataset without 
the variable of Discharge Hgb.  Subsequently, nine variables, ≤72hr Bleed, Hgb, BMI, >72hr 
Bleed, Highest Creatinine, Chest Drain, Procedure Type, ≤72hr Blood Transfusion Units, and 
Procedure Total Time, were removed in the similar manner in the full model, as the differences 
between Likelihood Ratio 2 values were all less than 3.841.   
When removing the variable of Age, however, the change over the Likelihood Ratio 2 
values was 5.99, indicating that this change was significant for 2 distributions with one degree 
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of freedom.  Hence, the variable of Age was retained because of its independently significance in 
the dataset of the model.  Similarly, the significance of four other variables, Lowest Hgb, 
Temporary Pacemaker, Chronic Lung Disease, and LOSICU, were confirmed by this trimming 
process.  Their corresponding 2 changes over the Likelihood Ratio 2 values were 8.03, 9.33, 
6.19, and 15.90, respectively.  As a result, the five variables were considered significant and 
were thus kept in the following trimmed model to further evaluate their impact on the LOS after 
TA TAVI collectively.  Table 21 presents the results of this trimming process.   
 
Table 21 
Report of Full Model Multivariate Trimming:  15-variable Dataset 
Variables Information Regression Model 
Variable Trimmed in Order Wald 2 df p 
Likelihood 
Ratio 2 df p Difference 
No trimming  ─ ─ ─ 56.09 16 0.000 ─** 
Discharge Hgb 0.01 1 0.935 56.09 15 0.000 0.00* 
≤72hr Bleed 0.06 1 0.801 56.03 14 0.000 0.06* 
Hgb  0.05 1 0.817 55.97 13 0.000 0.06* 
BMI  0.14 1 0.706 55.83 12 0.000 0.14* 
>72hr Bleed 0.51 1 0.476 55.98 11 0.000 0.15* 
Highest Creatinine  0.94 1 0.333 55.17 10 0.000 0.81* 
Chest Drain  0.94 1 0.333 55.51 9 0.000 0.34* 
Procedure Type 1.20 1 0.273 54.25 8 0.000 1.26* 
≤72hr Blood Transfusion 
Units 
1.47 2 0.481 52.85 6 0.000 1.40* 
Procedure Total Time  1.66 1 0.198 53.62 5 0.000 0.77* 
Age  4.05 1 0.044 49.52 4 0.000 5.99* 
Lowest Hgb  6.33 1 0.012 46.22 4 0.000 8.03* 
Temporary Pacemaker  6.68 1 0.010 43.52 4 0.000 9.33* 
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Chronic Lung Disease 8.25 1 0.004 47.43 4 0.000 6.19* 
LOSICU  13.53 1 0.000 33.62 4 0.000 15.90* 
Note.   
1.  N = 102.  Missing 11.3%.  Dependent variable:  LOS ordinal 
2.  The italicized group is the 15-variable dataset full model where no variable was trimmed. 
2.  A variable's overall test of significance indicates its overall influence on LOS, expressed in 
Wald 2(df),  p value.  A bolded p value with asterisk indicates p equals 0.050 or less. 
3.  Difference was calculated by subtracting the Likelihood Ratio 2 from the previous one, 
while the previous variable was removed from this model.  A bolded difference with asterisk 
indicates a value greater than 3.841.    
4.  Abbreviations.  LOSICU, length of stay in critical care; BMI, Body Mass Index; Hgb, 
hemoglobin; ≤72hr, less than or equal to the first 72 hours after TA TAVI ;  >72hr, more than 
72 hours after TA TAVI.   
 
4.7  Multivariate Ordinal Logistic Regression Model:  5-variable Trimmed Model 
Through the trimming process discussed above, five independent variables, including Age 
and Chronic Lung Disease from the Pre-procedure phase, Temporary Pacemaker from the Peri-
procedure phase, and LOSICU and Lower Hgb from the Post-procedure phase, were selected in 
the final trimmed multivariate ordinal logistic regression model to compute their overall effects 
on the dependent variable, LOS ordinal (Table 22).  
 
Table 22 
List of 5 Independent Variables of Trimmed Model 
Pre-procedure Phase Peri-procedure Phase Post-procedure Phase 
 
Age Temporary Pacemaker LOSICU 
 
Chronic Lung Disease 
 
Lowest Hgb 
Note. Dependent variable:  LOS ordinal. Abbreviations.  LOSICU, length of stay in critical 
care; Hgb, hemoglobin. 
 
4.7.1  5-variable trimmed model:  assumptions.  As tested in the full model, this 5-
variable dataset trimmed model had no multicollinearity problem.  When assessed by a full 
likelihood ratio test comparing the residual of the fitted location model to a model with varying 
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location parameters, however, the assumption of proportional odds was not met (2 (10) = 25.3, 
p = 0.005).  Therefore, separate binomial logistic regressions were conducted to further 
investigate the assumption of proportional odds.  Table 23 presents the results of separate 
binomial logistic regressions of this 5-variable dataset on the three dichotomous LOS ordinal 
categories, namely, LOS ordinal Category 1, LOS ordinal Category 2, and LOS ordinal 
Category 3.  As shown, the assumption of proportional odds might appear tenable for variables 
of Age, LOSICU, and Lowest Hgb, as the odds ratios for the three different binomial logistic 
regressions were similar.  However, the odds ratios for variables of Chronic Lung Disease and 
Temporary Pacemaker were not similar, indicating that the assumption of parallel odds for these 
two variables might not be tenable.   
 
Table 23 
5-variable Trimmed Model Proportional Odds:  Variables in the Equation 
 
B (parameter estimates) Exp(B) (Odds Ratio) 
Independent  
Variable 
LOS  
ordinal 
Category 1 
LOS  
ordinal 
Category 2 
LOS  
ordinal 
Category 3 
LOS  
ordinal 
Category 1 
LOS  
ordinal 
Category 2 
LOS  
ordinal 
Category 3 
Age 0.07 0.08 0.04 1.07 1.08 1.04 
Chronic Lung 
Disease 
2.16 1.39 0.49 8.63 4.02 1.63 
Temporary 
Pacemaker 
1.03 2.72 1.57 2.79 15.18 4.82 
LOSICU 0.02 0.03 0.04 1.02 1.03 1.04 
Lowest Hgb -0.06 -0.04 -0.02 0.94 0.96 0.98 
Constant -2.99 -5.21 -1.59 0.05 0.01 0.20 
   
4.7.2  5-variable trimmed model:  goodness of fit.  Despite the large percent of cells 
with zero frequencies (75%), overall the model was a good fit.  The Deviance test indicates that 
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the trimmed model was a good fit to this dataset with 2 (307) = 233.5, p = 0.999.  Likewise, the 
Pearson test reports similar results ( 2 (307) = 276.2, p = 0.896).  Furthermore, the Pseudo R-
square reports Cox and Snell of 0.40 and Nagelkerke of 0.43, and the final model statistically 
significantly predicts the dependent variable, LOS ordinal, over and above the intercept-only 
model, 2 (5) = 53.6, p = 0.000, in this model, all indicating that this 5-variable trimmed model 
met the goodness of fit requirement.   
4.7.3  5-variable trimmed model:  results.  Table 24 reports the five independent 
variables’ odds ratios and Wald 2 values in association with the dependent variable, LOS 
ordinal, in this trimmed model.  A p value equal or less than 0.050 was considered significant.  
As shown, the sample size was 105 with a missing response of 8.7%.  Over 55% of the TA TAVI 
patients had a LOS that was less than eight days.    
Overall, all of the five independent variables had p values less than 0.050, indicating their 
statistically significant associations with the LOS after TA TAVI.  LOSICU had the largest Wald 
2 of 12.89 (p = 0.000), followed by Chronic Lung Disease (Wald 2 = 9.78, p = 0.002), 
Temporary Pacemaker (Wald 2 = 9.35, p = 0.002), Lowest Hgb (Wald 2 = 6.11, p = 0.013), 
and Age (Wald 2 = 4.05, p = 0.044).  The odds ratios of the five variables indicated that four 
variables, Temporary Pacemaker, Chronic Lung Disease, Age and LOSICU, were associated 
with increased odds in having longer LOS.  For instance, having chronic lung diseases increased 
the odds of having longer LOS by 3.60 times while the use of temporary pacemaker at the 
completion of the TA TAVI procedure increased the same odds by 4.95 times.  In addition, every 
unit of increase in the age and the length of stay in the critical care increased the chances of 
having longer LOS by 1.05 and 1.03 times, respectively.  By contrast, a higher baseline 
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hemoglobin level during hospitalization was associated with a lower likelihood of having longer 
LOS by 0.97 times.   
 
 
Table 24 
Report of Multivariate Ordinal Logistic Regression 5-variable Trimmed Model:  5-variable 
Dataset 
 
Percent/ 
Mean (SD) OR [95% CI] Wald 2 (df) p 
Dependent Variable 
    
LOS ordinal 
                Less than 6 days 23.8% 
               6 - 7 days 31.4% 
               8 - 12 days 18.1% 
               More than 12 days 26.7% 
   
Independent Variables 
    
Chronic Lung Disease 
  
9.78 (1) 0.002* 
             No 61.9% 1 
               Yes 38.1% 3.60 [1.61, 8.02) 
  
Temporary Pacemaker  
  
9.35 (1) 0.002* 
             No 81.9% 1 
               Yes 18.1% 4.95 [1.78, 13.81] 
  
Age  78.7 (8.5) 1.05 [1.00, 1.10] 4.05 (1) 0.044* 
Lowest Hgb  95.6 (15.1) 0.97 [0.94, 0.99] 6.11 (1) 0.013* 
LOSICU  62.4 (100.6) 1.03 [1.01, 1.04] 12.89 (1) 0.000* 
Note.   
1.  N = 105.  Missing 8.7%. 
2.  The italicized group for each variable is the reference group for the comparison.   
3.  The odds ratio indicates to what extent the variable influences LOS relative to its reference 
group.  A ratio greater than 1.00 indicates an increase in LOS, while a ratio less than 1.00 
indicates a decrease in LOS.   
4.  A variable's overall test of significance indicates its overall influence on LOS, expressed in 
Wald 2(df), p value.  A bolded p value with asterisk indicates p equals 0.050 or less. 
5. Abbreviations.  LOS, length of stay; LOSICU, length of stay in critical care; Hgb, 
hemoglobin. 
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4.8  Multivariate Ordinal Logistic Regression:  6-variable Trimmed Model with STS 
Clinically, the STS risk score is used as a surrogate score to primarily support case 
selection in TAVI procedures.  Due to its high missing rate in this study, however, the variable of 
STS was first excluded from the full model (Table 22).  In a post-hoc analysis to examine its 
potential relevance, STS was re-entered in the multivariate ordinal logistic regression with the 
other five independently significant predictors of the LOS after TA TAVI.  In the following 
section, the results of this 6-variable dataset regression trimmed model are presented and 
discussed.  Table 25 lists the six variables included in this model.      
 
Table 25 
List of 6 Independent Variables of 6-variable Trimmed Model with STS 
Pre-procedure Phase Peri-procedure Phase Post-procedure Phase 
 
Age Temporary Pacemaker LOSICU 
 
Chronic Lung Disease 
 
Lowest Hgb 
 
STS 
  Note. Dependent variable:  LOS ordinal. Abbreviations.  LOSICU, length of stay in 
critical care; STS, the Society of Thoracic Surgeons risk score; Hgb, hemoglobin. 
  
4.8.1  6-variable trimmed model with STS:  assumptions.  As tested in the full model, 
there was no collinearity problem within this 6-variable dataset model.  To test the assumption of 
proportional odds, a full likelihood ratio test was conducted to compare the residual of the fitted 
location model to model with varying location parameters (2 = 12.4, , p = 0.403), indicating that 
this assumption was met in this model.   
4.8.2  6-variable trimmed model with STS:  goodness of fit.  Overall, the statistic tests 
showed that this model was a good fit.  The Deviance test reports the goodness of fit of this 
model with 2 (307) = 119.9, p = 0.986.  Correspondingly, the Pearson test shows that the model 
was a good fit with 2 (307) = 148.3, p = 0.657.  The final model statistically significantly 
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predicts that the dependent variable, LOS ordinal, over and above the intercept-only model, 2 (6) 
= 32.0, p = 0.000, indicating the goodness of fit of the model.  In addition, the findings of the 
Pseudo R-square tests and the Likelihood-ratio test are supportive (Cox and Snell R
2
 = 0.44; 
Nagelkerke R
2
 = 0.44; and McFadden R
2
 = 0.21). 
4.8.3  6-variable trimmed model with STS:  results.  Table 26 reports the results of this 
6-variable trimmed model with the variable of STS.  As shown, the sample size was 55 with a 
missing rate of 52.2%.  The variable of STS had an odds ratio of 1.05 that was not statistically 
significant (Wald 2 (1) = 3.76, p = 0.053).   
Overall, compared to the results of the 5-variable trimmed model without STS discussed 
above, this 6-variable regression model showed that the six variables demonstrated similar 
predicting effects on the LOS after TA TAVI, but with varying statistical significances.  For 
instance, both models found that the incidence of chronic lung disease in TA TAVI patients had 
statistically significant effect on increasing the odds of having longer LOS (OR = 3.60, Wald 2 
(1) = 9.78 and 10.02, p = 0.002 and 0.002, respectively).  Likewise, the variable of LOSICU was 
shown to be another statistically significant predictor of the LOS after TA TAVI in both models 
(OR = 1.03; Wald 2 = 12.89 and 5.34, p = 0.000 and 0.021, respectively).   
 
Table 26 
Report of Multivariate Ordinal Logistic Regression 6-variable Trimmed Model with STS:   
6-variable Dataset 
 
Percent/ 
Mean (SD) OR [95% CI] Wald 2 (df) p 
Dependent Variable 
    
LOS ordinal 
                Less than 6 days 25.5% 
               6 - 7 days 23.6% 
               8 - 12 days 21.8% 
               More than 12 days 29.1% 
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Independent Variables 
    
Chronic Lung Disease 
  
10.02 (1) 0.002* 
             No 65.5% 1 
               Yes 34.5% 3.60 [1.61, 8.02] 
  
Temporary Pacemaker  
  
2.11 (1) 0.147* 
             No 74.5% 1 
               Yes 25.5% 4.95 [1.78, 13.81] 
  
Age  77.6 (8.4) 1.05 [1.00, 1.10] 1.63 (1) 0.202* 
STS  8.5% (6.6) 1.05 [1.00, 1.10] 3.76 (1) 0.053* 
Lowest Hgb  97.5 (14.4) 0.97 [0.94, 0.99] 3.64 (1) 0.056* 
LOSICU  66.0 (129.4) 1.03 [1.01, 1.04] 5.34 (1) 0.021* 
Note.   
1.  N = 55.  Missing 52.2%. 
2.  The italicized group for each variable is the reference group for the comparison.   
3.  The odds ratio indicates to what extent the variable influences LOS relative to its 
reference group.  A ratio greater than 1.00 indicates an increase in LOS, while a ratio less 
than 1.00 indicates a decrease in LOS.   
4.  A variable's overall test of significance indicates its overall influence on LOS, expressed 
in Wald 2(df),  p value.  A bolded p value with asterisk indicates p equals 0.050 or less. 
5. Abbreviations.  LOS, length of stay; LOSICU, length of stay in critical care; STS, the 
Society of Thoracic Surgeons risk score; Hgb, hemoglobin. 
 
4.9  6-variable Trimmed Model with STS Multivariate Trimming 
Despite its high missing data rate in this study, the potential impact of STS on the LOS 
after TA TAVI was worth further investigation given its clinical relevance in TAVI procedures.  
Hence, multivariate trimming on the 6-variable trimmed model with STS was conducted to 
evaluate the potential independent significance of STS on the LOS after TA TAVI in relation to 
other five predictors.   
4.9.1  Results.  Table 27 presents the results of this trimming process.  Compared to other 
variables’ Wald 2 values, the variable of Age had the smallest Wald 2 (1.63) in this initial 6-
variable dataset, thus became the first one to be removed.  The difference between the two values 
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of Likelihood Ratio 2 were then computed and compared with the critical value of  2 with one 
degree of freedom (3.841).  Following this iterative process, the variables of Age, Temporary 
Pacemaker, and Lowest Hgb were removed subsequently.  By contrast, the independent 
significance of STS, Chronic Lung Disease, and LOSICU could not be neglected.  Thus, the three 
variable were collectively kept in the following multivariate ordinal logistic regression 3-variable 
dataset trimmed model to evaluate their predicting significance on the LOS after TA TAVI.     
 
Table 27 
Report of 6-variable Trimmed Model with STS Multivariate Trimming:  6-variable Dataset 
Variables Information Regression Model 
Variable Trimmed in Order Wald 2 df p 
Likelihood 
Ratio 2 df p Difference 
No trimming  ─ ─ ─ 32.00 6 0.000 ─ * 
Age 1.63 1 0.202 30.30 5 0.000 1.70* 
Temporary Pacemaker  2.14 1 0.143 28.62 4 0.000 1.68* 
Lowest Hgb  2.87 1 0.090 26.55 3 0.000 2.07* 
STS 5.71 1 0.017 34.04 2 0.000 7.49* 
Chronic Lung Disease 7.24 1 0.007 13.55 2 0.001 20.49* 
LOSICU 5.99 1 0.014 18.15 2 0.000 4.60* 
Note.   
1.  N = 55.  Missing 52.2%.  Dependent variable:  LOS ordinal. 
2.  The italicized group is the 6-variable trimmed model with STS where no variable was 
trimmed. 
2.  A variable's overall test of significance indicates its overall influence on LOS, expressed in 
Wald 2(df),  p value.  A bolded p value with asterisk indicates p equals 0.050 or less. 
3.  Difference was calculated by subtracting the Likelihood Ratio 2 from the previous one, 
while the previous variable was removed from this model.  A bolded difference with asterisk 
indicates a value greater than 3.841.    
4.  Abbreviations.  LOSICU, length of stay in intensive care unit; Hgb, hemoglobin; STS, the 
Society of Thoracic Surgeons risk score.   
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4.10  Multivariate Ordinal Logistic Regression:  3-variable Trimmed Model with STS 
4.10.1  3-variable trimmed model with STS:  assumptions.  In this 3-variable trimmed 
model with STS, there were three variables, STS, Chronic Lung Disease, and LOSICU, identified 
from the multivariate trimming process discussed above.  The assumptions and goodness of fit of 
this model were first tested.   
As tested in the full regression model, there was no multicollinearity issue in this model.  
Moreover, a full likelihood ratio test showed that the assumption of proportional odds was not 
met for this model (2 = 24.2, p = 0.000).  To further explore this assumption, therefore, separate 
binomial logistic regression analyses were conducted on the three dichotomized cumulative 
categories of LOS ordinal, namely, LOS Ordinal Category 1 (LOS more than 12 days), LOS 
Ordinal Category 2 (LOS more than 7 days), and LOS Ordinal Category 3 (LOS more than 5 
days).  Table 28 presents the results of the separate binomial logistic regression, which showed 
that the assumption of the proportional odds might be tenable for the variables of STS and 
LOSICU because of their similar odds ratios.  The odds ratios of the variable of Chronic Lung 
Disease, however, varied among the three categories of LOS ordinal, indicating that this 
assumption might not be tenable for the variable of Chronic Lung Disease in this model.    
 
Table 28 
3-variable Trimmed Model with STS Proportional Odds:  Variables in the Equation 
 
B (parameter estimates) Exp(B) (Odds Ratio) 
Independent  
Variable 
LOS  
ordinal 
Category 1 
LOS  
ordinal 
Category 2 
LOS  
ordinal 
Category 3 
LOS  
ordinal 
Category 1 
LOS  
ordinal 
Category 2 
LOS  
ordinal 
Category 3 
Chronic 
Lung Disease 
2.68 2.12 0.25 14.59 8.35 1.29 
STS 0.15 0.38 0.16 1.16 1.46 1.17 
LOSICU 0.01 0.05 0.03 1.01 1.05 1.03 
Constant -4.17 -5.78 -1.56 0.02 0.00 0.21 
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4.10.2  3-variable trimmed model with STS:  goodness of fit.  Overall, this trimmed 
model was a good fit for this 3-variable dataset.  The results of statistic tests for goodness of fit 
are reported in the Table 29.   
 
Table 29 
3-variable Trimmed Model with STS:  Goodness of Fit Test 
Pseudo R-Square Tests 
 
R
2
 
   Cox and Snell 0.37 
   Nagelkerke 0.40 
   McFadden 0.17 
   
Likelihood-Ratio Test 
 
-2 Log 
Likelihood 2 df p 
Intercept-only 157.7 
   Final 131.2 26.5 3 0.000 
Overall Goodness-of-Fit Tests 
  
2 df p 
Pearson 
 
159.7 165 0.602 
Deviance 
 
131.2 165 0.976 
 
 
4.10.3  3-variable trimmed model with STS:  results.  Table 30 presents the results of 
this 3-variable trimmed model with STS.  As shown, the sample size was 57 with a missing 
response rate of 50.4 %.  All of the three variables appeared to be statistically significant 
predictors of the LOS after TA TAVI (p < 0.050).  The variables of Chronic Lung Disease and 
LOSICU remained statistically significant in predicting the LOS after TA TAVI.  As shown in 
Table 30, the variable of STS had an odds ratio of 1.16, with Wald 2 (1) = 5.71, p = 0.017.     
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Table 30 
Report of Multivariate Ordinal Logistic Regression 3-variable Trimmed Model with STS:   
3-variable Dataset 
 
Percent/ 
Mean (SD) OR [95% CI] Wald 2 (df) p 
Dependent Variable 
    
LOS ordinal 
                Less than 6 days 24.6% 
               6 - 7 days 24.6% 
               8 - 12 days 22.8% 
               More than 12 days 28.1% 
   
Independent Variables 
    
Chronic Lung Disease 
  
9.39 (1) 0.002* 
             No 66.7% 1 
               Yes 33.3% 5.98 [1.91, 18.78] 
  
STS 8.4% (6.6) 1.16 [1.03, 1.30] 5.71 (1) 0.017* 
LOSICU  67.1 (127.3) 1.02 [1.00, 1.04] 6.20 (1) 0.013* 
Note.   
1.  N = 57.  Missing 50.4%. 
2.  The italicized group for each variable is the reference group for the comparison.   
3.  The odds ratio indicates to what extent the variable influences LOS relative to its reference 
group.  A ratio greater than 1.00 indicates an increase in LOS, while a ratio less than 1.00 
indicates a decrease in LOS.   
4.  A variable's overall test of significance indicates its overall influence on LOS, expressed in 
Wald 2(df),  p value.  A bolded p value with asterisk indicates p equals 0.050 or less. 
5. Abbreviations. LOSICU, length of stay in intensive care unit; STS, the Society of Thoracic 
Surgeons risk score. 
 
4.11  Chapter Summary 
In this chapter, we discussed the results of the statistic analyses of the 62 candidate 
variables in association to the LOS after TA TAVI.  Univariate statistics were first performed to 
provide the descriptive information of the 62 independent variables as well as the dependent 
variable, LOS ordinal.  From the bivariate ordinal logistic regression analyses, eighteen variables 
were initially identified for the multivariate ordinal logistic regression analysis.  Due to 
multicollinearity issue, however, only fifteen of them were finally selected in the full model.   
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The results of the 15-variable dataset multivariate ordinal logistic regression full model 
indicated that, among the fifteen indepdent variables, three variables, including Chronic Lung 
Disease, Temporary Pacemaker, and LOSICU, appeared to have statistically significant effect on 
the LOS after TA TAVI, thus leading to the multivariate trimming for further investigating the 
interrelationships of the fifteen variables in terms of their impact on the LOS after TA TAVI.  As 
a result, five variables, including Chronic Lung Disease, Temporary Pacemaker, Age, Lowest 
Hgb, and LOSICU, emerged to be independently significant predictors of the LOS after TA 
TAVI.   
 Despite its clinical relevance in TAVI procedures, the variable of STS was initially 
excluded from the 15-variable dataset full model, due to its high missing response rate in this 
study, but was included in a full regression model with the other five significant predictors to 
estimate its influence on the LOS after TA TAVI.  The statistic regression models reported 
similar findings.  For instance, with the addition of the variable of STS, two of the five predictor 
variables, namely, Chronic Lung Disease and LOSICU, remained as statistically significant 
predictors of the LOS after TA TAVI, while the effects of the other three predictor variables, 
including Age, Temporary Pacemaker, and Lowest Hgb, changed and became statistically 
insignificant.   
Although not statistically significant in the multivariate regression full model (p = 0.056), 
the variable of STS was significantly associated with LOS in the bivariate analysis.  To further 
distinguish the impact of this variable in relation to the other five predictors, multivariate 
trimming was performed again in the 6-variable dataset model.  As a result, two variables, 
including Chronic Lung Disease and LOSICU, remained statistically significant predictors of the 
LOS after TA TAVI.  Morevoer, the potential impact of STS appeared to be too significant to be 
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neglected.  Therefore, the three variables were collectively included in a separate regression 
model to evaluate their combined associations with the LOS.  The results revealed that all three 
variables were statistically significant predictors of the LOS after TA TAVI.  Nonetheless, 
considering the small sample size in this model, the influence of STS warrants further 
investigation as a potentially relevant predictor of the LOS after TA TAVI.           
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Chapter Five:  Discussion 
The purpose of this study was to identify the individual characteristics, procedural factors 
and complications, and patient care factors were predictive of LOS after TA TAVI, and to what 
extent they predicted it.  In the following sections, we will compare this study’s key findings 
with previous findings, appraise their implications, and discuss the methodological strengths as 
well as limitations. 
5.1  Key Findings Compared with Literature Review  
First, compared to the findings of the literature reviews, this study’s key findings are 
consistent with that of some studies.  For example, we found that the mean age of our sample 
was 78.8 years old (SD = 8.7).  Every additional year of increase in age was associated with 
increased odds of having longer LOS after TA TAVI (OR = 1.05), a relatively large overall 
effect of Wald 2 of 4.05, p = 0.044.  Other studies have also reported that, in general, advanced 
age was an independently important predictor of LOS in older adults (Kaysar et al., 2008; 
Kofteridis et al., 2009; Morse et al., 2010).  Similarly, the level of creatinine is used in clinical 
practice to measure renal function.  In our study, the variable of Highest Creatinine, which 
described TA TAVI patients’ highest creatinine level during hospitalization, was initially 
estimated to be a potentially significant predictor based on its bivariate odds ratios, but was 
excluded through the trimming process due to its statistically insignificant overall effect.  This 
finding is consistent with that of the studies of Van Linden et al. (2011), who reported that acute 
kidney injury, resulting from the use of contrast media was not significantly associated with 
prolonged LOS in post-TAVI patients.   
Second, this study’s findings have addressed certain gaps in the literature.  For example, 
despite the general consensus that factors, including co-morbidities and iatrogenic complications, 
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were associated with prolonged LOS in the hospitalized older adults in general, little has been 
reported in relation to TA TAVI (Kaye et al., 2009; Bjorkelund et al., 2011).  Our analysis begins 
to address this gap.  In this study, chronic lung disease, as one example of co-morbidities, was 
shown to be significantly predictive of the LOS after TA TAVI.  Similarly, another significant 
predictor is the need for a temporary pacemaker at the completion of TA TAVI, indicating that 
procedural complications, including dysrhythmia derived from aberrant conduction, did 
significantly influence the LOS after TA TAVI.   
Third, this study’s findings provide additional details that complement that of other 
studies.  With regard to blood transfusion related variables, previous studies reported that blood 
transfusion and general anesthesia were associated with prolonged LOS (Di Mario et al., 2012; 
Mwipatayi et al., 2013).  In the bivariate analyses of this study, we found that postoperative 
bleeding events and the use of blood products increased the odds of having longer LOS.  
However, the results of the multivariate trimming showed that, in the context of other variables, 
including Age, Chronic Lung Disease, Temporary Pacemaker, LOSICU, and Lowest Hgb, the 
bleeding and blood transfusion related variables were not independent predictors of the LOS 
after TA TAVI.  Nonetheless, we did find that the lowest value of the hemoglobin level of TA 
TAVI patients during hospitalization played a significant role in predicting LOS.  Clinically, 
hemoglobin is an important indicator of anemia.  Anemia is prevalent in older population, and 
can be aggravated by postoperative bleeding.  Literature reported that anemia-induced blood 
transfusion more likely prolonged the LOS of older adults (Collins, Daley, Henderson, & Khuri, 
1999).  In this regard, this study is consistent in reporting that, when comparing the lowest values 
of the hemoglobin level among the TA TAVI patients during hospitalization, the lower the 
hemoglobin level was, the more likely the patient would have longer LOS.   
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Last, despite lack of relevant findings in previous studies, the significant impact of the 
LOS in critical care on overall LOS was evidently self explanatory and statistically supported in 
this study.  However, as LOS in critical care is a multifaceted phenomenon attributed to various 
factors, future studies may be needed to further explore the context of this surrogate measure in 
order to gain better understanding of its impact on the LOS after TA TAVI patients.  
5.2  Findings Related to Study Models 
No previously developed conceptual frameworks readily applicable to this study were 
found in the literature review.  To address this study’s questions, we developed a map-like 
approach, which consists of two models, namely, the Predicting LOS after TA TAVI:  TA TAVI 
Surgical Process Model (Figure 1) and the Predicting LOS after TA TAVI:  Conceptual Model 
(Figure 2).   
In developing the two models, we carefully consulted the findings of literature review 
and the presentation of clinical data relevant to possible structure and constructs.  For instance, 
several studies reported that factors, including patients’ individual characteristics (i.e., co-
morbidities) and procedural complications (i.e., acute kidney injury), influenced LOS (Kofteridis 
et al., 2009; Mwipatayi et al., 2013).  To some extent, such findings have given the empirical 
evidence in supporting our assumptions that TA TAVI-related LOS might be attributed to 
individual characteristics (i.e., demographic characteristics) in the context of TA TAVI (i.e., 
postoperative TA TAVI complications).  In addition, we examined the patterns of the available 
clinical dataset, and postulated that the trajectory of undergoing TA TAVI could be divided into 
phases (i.e., the Pre-procedure phase, the Peri-procedure phase, and the Post-procedure phase) to 
provide an clinically intuitive yet systematically logical approach in identifying potential 
candidate variables and examining the inter-relationships.   
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Both the findings from this study and the literature review have supported the feasibility 
and appropriateness of the two models in this study.  First, by using the two models, we 
demonstrated that there were independent predictors of LOS from different phases throughout 
the TA TAVI process.  For example, identifying the demographic variable of Age from the Pre-
procedure phase, the variable of Temporary Pacemaker from the Peri-procedure phase, and the 
variable of Lowest Hgb from the Post-procedure phase, supported the feasibility of defining the 
TA TAVI procedure phases.  Second, we confirmed that by using the two models, this study’s 
findings were not only supportive of the assumptions underlying the research question, but they 
also correlated with that of other studies.  One such example is the finding of the variable of 
Chronic Lung Disease.  Due to the intrinsically complex nature of interactions between 
pulmonary diseases and cardiovascular functions, chronic obstructive pulmonary disease (COPD) 
was initially considered and selected as one of the 62 candidate variables.  Moreover, the 
literature review showed that, as one of the common respiratory disorders in older adults, COPD 
was one of the predictors of prolonged LOS (Chang, Calligaro, Lombardi, & Dougherty, 2003), 
further supporting the selection of this variable for analysis.  Finally, in this study, the variable of 
Chronic Lung Disease was demonstrated as statistically predictive of LOS TA TAVI.  Therefore, 
the usefullness of the two models in this study is supported.   
In summary, we consider that the two models, the Predicting LOS after TA TAVI:  
Model of Surgical Process (Figure 1) and Conceptual Model (Figure 2), and have provided a 
relevant and suitable organizing framework for this study.  As this study is exploratory, however, 
we acknowledge the developmental and experimental nature of the two models.  Thus, further 
refining through more studies are recommended.   
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5.3  Implications 
In general, older adults are more frail and susceptible to adverse outcomes such as 
delayed recovery and prolonged LOS postoperatively (Kaye et al., 2009; Bjorkelund et al., 2011).  
Due to their higher surgery risk or other prohibitive conditions including peripheral artery 
disease or atherosclerotic disease, more older adults with severe symptomatic AS are not 
candidates for conventional SAVR or TF TAVI.  Therefore, TA TAVI is an appropriate 
alternative therapy for a selected patient population.  However, as discussed previously, in the 
literature, little has been explored about the LOS after TA TAVI patients.  This study found that 
median LOS was seven days, which was longer than the median hospital stay of six days 
reported by the Society of Thoracic Surgeons/ American College of Cardiology Transcatheter 
Valve Therapy (STS/ACC TVT) Registry (Mack et al., 2013).  The findings of this study may 
have implications relevant to nursing education and practice and policy making in the context of 
the LOS after TA TAVI patients.      
At the nursing education level, identifying the predictors of the LOS after TA TAVI may 
increase nurses’ knowledge with regard to TA TAVI-specific patient care.  Generally speaking, 
lengthy LOS is an undesirable and detrimental outcome, especially for older adults.  Although 
prolonged LOS is inevitable under certain circumstances, studies ascertained that quality of 
nursing care played an important role in improving the quality of patient care, thus reducing the 
likelihood of prolonged LOS (Thungjaroenkul, Cummings, & Embleton, 2007; Stauber, 2013).  
One way nurses can improve the quality of care is to increase relevant knowledge while 
individualizing patient care.  Specifically, in this study, chronic lung disease was demonstrated to 
have a statistically significant positive correlation with the LOS after TA TAVI, thus highly 
likely to increase TA TAVI patients’ risk of having adverse sequelae derived from lengthy LOS 
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(i.e., de-conditioning or delayed recovery).  As stated previously, COPD was already found to be 
the predictor of prolonged LOS in other surgeries (Chang et al., 2003).  Fried, Fragoso, and 
Rabow (2012) stated that COPD was “characterized by high symptom burden, healthcare 
utilization, mortality and unmet needs of patients and caregivers” (p.1254).  Hence, the 
adversarial impact of COPD on older adults should not be taken lightly.  Knowledge of the 
existence of this predictor could alert nurses and motivate them to become more familiar with 
COPD-related care management for TA TAVI patients with such health challenges.  Another 
indicator which could increase nursing knowledge is the predictor of temporary pacemaker use at 
the completion of TA TAVI.  This may call nurses’ attention to increase relevant telemetry 
monitoring and become more attuned to nursing skills including electrocardiogram interpretation, 
especially during the Peri-procedure phase.    
At the nursing practice level, it is acknowledged that the key findings of this study are 
mostly related to factors that are essentially non-modifiable, for example, patient age and 
medical history.  Nonetheless, the findings of this study may still have practice implications on 
how to care for this patient population, especially from the perspective of de-conditioning 
prevention.  Gillis and MacDonald (2005) described that de-conditioning was a “complex 
process of physiological change following a period of inactivity, bedrest or sedentary lifestyle”, 
and in hospitalized older, may occur acutely within “as little as two days of bedrest” (p. 17).  
Moreover, predictable effects of de-conditioning were often seen through the functional losses, 
which were often aggravated by lengthy LOS, and in turn increased a patient’s frailty.  In this 
study, we found that the mean and median LOS after TA TAVI patients was 11.1 days and 7.0 
days, respectively, longer than that of other types of interventions.  In addition, despite its high 
missing data rate, in the bivariate analyses on the Functional Assessment variables, we noted that 
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the variable of CSHA CFS (Table 9) had the odds ratio of 1.59 (p = 0.230), meaning that, while 
analyzing this frailty measurement variable in relation to LOS, high CSHA CFS scores might 
positively increase the odds of having longer LOS after TA TAVI.  Therefore, to purposefully 
prevent de-conditioning in TA TAVI patients, recommendations to nursing practice include 
continuing education on de-conditioning management, and early implementation of functioning-
improving strategies during hospitalization (Gillis & MacDonald, 2005; Kleinpell et al., 2008; 
Kosse et al., 2013).  On the other hand, because of the high missing response rates of the 
Functional Assessment variables included in this study, it is recommended that future studies 
explore in depth the inter-relationships they may have with the LOS after TA TAVI.  Moreover, 
it is recognized that this study included only five functional assessment measures.  The five 
selected measures might not inclusively capture appropriate predictors of the LOS after TA 
TAVI.  Therefore, future studies could focus on other types of functional assessment to evaluate 
their predictive effects.         
At the nursing policy level, LOS is often an important outcome measure of quality of care 
and resource consumption.  As TA TAVI procedure is not only indicated for saving lives, but 
more importantly for enhancing quality of life in older adults with severe AS, it seems desirable 
if the TA TAVI patient can be discharged as expected.  Fried et al. (2012) stated that nursing 
practice might incorporate streamlined care guidelines (i.e., pathways) that were specifically 
developed to supplement independent clinical decision making based on individualized patient 
needs.  In this regard, the findings of this study may have implications.  For instance, this study 
found that TA TAVI led to relatively longer LOS, and several factors (i.e., respiratory challenges 
or hemoglobin level) appeared to prolong it.  Although nurses can do little to alter the 
pathophysiological nature of TA TAVI patients’ medical conditions, by identifying common 
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characteristics in this population, nurses may be able to make positive changes in nursing 
practice that cater to their unique care needs.  Moreover, in consideration of the impact of long 
LOS on potential de-conditioning in TA TAVI patients during hospitalization, clinical pathways 
for preventing de-conditioning in this patient population may be specifically developed based on 
the best practice evidence available.  Nonetheless, it is recognized that, although this study 
provides a preliminary identification of the predictors of the LOS after TA TAVI, it did not 
explore evidence in nursing practice relevant to clinical pathway development for de-
conditioning management.  Future research and analysis of best practice guidelines in this 
direction are required to provide substantive empirical evidence.    
Based on the discussion above, we are cautious in making recommendations on changing 
established nursing practice in the context of TA TAVI-related LOS.  Hence, in consideration of 
the findings of this study, we recommend that 1) in practice, health care practitioners including 
nurses may increase their awareness of the existence of these identified predictors; and 2) in 
research, future studies may focus on validating the findings of this study, exploring other 
possible predictors, and appraising the best evidence in nursing practice.          
5.4  Methodological Strengths  
Methodologically, this study has several strengths, including developing a structured 
approach in identifying and organizing variables, adopting a stepwise process in data analyses, 
and applying statistical techniques of multivariate trimming.   
The first and foremost challenge that this study had to deal with was how the multiple 
candidate variables could be reasonably identified and feasibly handled.  To address this 
challenge, we designed a systematically structured approach.  Specifically, we first conducted 
comprehensive literature reviews and consulted experts to identify the 62 candidate variables.  
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Theoretically, we then developed the Predicting LOS after TA TAVI:  TA TAVI Surgical 
Process Model (Figure 1) and the Predicting LOS after TA TAVI:  Conceptual Model (Figure 2) 
as the underlying framework to classify and organize the candidate variables.  Furthermore, to 
ensure the accuracy in the process of data collection, we developed the Predicting LOS after TA 
TAVI:  Data Collection Form (Appendix A) and Code Manual (Appendix B), and consistently 
applied them in the retrospective chart review.  As the primary threat to data reliability and 
validity while using a chart review method is the subjective interpretation in data collection, we 
mitigated this impact by selecting the variables that were either objectively measured or 
explicitly described, thus maximizing the reproducibility and quality of the data collected 
(Worster & Haines, 2004; Gregory & Radovinsky, 2012).   
During data analysis, the major challenge we faced was how the 62 independent 
variable’s impact on LOS could be statistically evaluated.  For this challenge, we used an 
iterative statistical process by which we first used bivariate ordinal logistic regression to explore 
the 62 independent variables’ individual impact on LOS, and then included the selected 
significant variables in the multivariate ordinal logistic regression full model.  This stepwise 
process is systematic and replicable if needed in future studies with different sample sizes.    
Finally, to pinpoint the variables that were independently significant predictors of the 
LOS after TA TAVI, we applied the multivariate trimming technique.  In consideration of 
sample size and covariance effect, the application of this robust process was crucial in 
reinforcing the findings of this study.  Furthermore, the power analysis reviewed that, in 
multivariate logistic regression, a sample size of ten was required for each variable in the model 
(Peduzzi et al., 1996).  After the multivariate trimming, the number of independent variables 
decreased to five, which made the total sample size of 102 sufficient for this study.     
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5.5  Limitations 
One of the methodological shortcomings is the study’s sample.  This study included 
subjects who were carefully screened and selected for the TA TAVI procedure.  Moreover, 
because this study used a single study center’s clinical data, the sample only represented this 
center’s individual experience of TA TAVI.  Therefore, the generalization of this study’s 
findings is unknown.  In addition, to enhance the rigor of a study using retrospective chart review, 
ideally, a team of at least two data abstractors was recommended for data collection, and kept 
blind to the purpose of the study (Gregory & Radovinsky, 2012).  This, however, was not 
feasible for this study given constraints in resources. Nonetheless, the strategies that this study 
employed to mitigate the impact of such limitations included the development of the Data 
Collection Form (Appendix A) and the Code Manual (Appendix B) and consistent application of 
the two forms in the process of data collection.  Recommendations for future research are using 
multi-center databases and applying more rigorous data collection techniques.      
Other limitations are related to the variable selection and missing data rates.  Although 
the 62 variables included were systematically and comprehensively selected, the list is unlikely 
exhaustive, thus recommending future research to explore other relevant variables.  For example, 
clinical feedback suggested that pain related to the TA TAVI procedure postoperatively might 
have potential impact on LOS.  Due to lack of data, however, pain was not included in this 
study’s variable selection.  In addition, several variables had high missing data rates.  Among the 
115 samples of this study, it is noted that only 63 had the STS risk scores (missing 45.2%), and 
the majority of the 63 STS risk scores (95%) were recorded after 2012.  Nonetheless, statistic 
analyses in this study did show that, despite its high missing response rate, the STS risk score 
appeared to have significant impact on the LOS after TA TAVI patients.  Therefore, in 
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consideration of its clinical relevance, it is recommended that future studies may explore in depth 
the impact of STS risk score on the LOS after TA TAVI with larger sample size.  Likewise, in 
this study, the five Functional Assessment variables were excluded in the early analytic stage.  
Their high missing response rates may have contributed to their early exclusion, thus making the 
estimates of their impact on LOS underexplored in this study.  Furthermore, the limited sample 
size may also have caused some variables not to be statistically significant predictors.  In this 
regard, it is recommended that future research explore the inter-relationships between functional 
assessment variables and the LOS after TA TAVI with sufficient sample size.  
5.6  Conclusion 
With an ageing population, the prevalence of AS is expected to be increasingly common.  
Over the years, TA TAVI has been proven to be a feasible procedure with safety and efficacy for 
the non-operative older adults who are at higher risk for SAVR and other TAVI interventions.   
In this study, with the purpose of identifying the predictors of the LOS after TA TAVI, 
we conducted a retrospective chart review on the 128 medical charts of TA TAVI patients, 
collected data of the 62 potential predictors selected from the literature review and consultations 
with experts, and analyzed them by using bivariate and multivariate ordinal logistical regression 
models.  As a result, the mean and median LOS after TA TAVI was elevent and seven days, 
respectively.  Among the 62 candidate variables, we have found that five appeared to 
significantly predict the LOS after TA TAVI.  These five predictors include the patient’s age, the 
lowest hemoglobin level during hospitalization, the medical history of chronic lung diseases, the 
need for using temporary pacemaker upon the completion of the procedure, and the length of 
stay in critical care.  Based on this study’s findings, we conclude that if a TA TAVI patient has 
chronic lung disease or needs a temporary pacemaker when the TA TAVI is completed, the odds 
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of having longer LOS will likely increase.  Likewise, the older the patient is, the longer the LOS 
after TA TAVI will likely be.  Moreover, postoperative stay in the critical care increasingly 
affects one’s chance of having longer LOS after TA TAVI.  Conversely, when comparing two 
TA TAVI patients’ lowest level of hemoglobin, the one with the lower value is likely to have 
increased odds of having longer LOS after TA TAVI.  Furthermore, as TA TAVI appeared to 
have longer LOS than other interventions, it is highly recommended that nursing practice be 
more proactive in managing potential de-conditioning that may result from longer LOS after TA 
TAVI.     
Moreover, this study’s findings are consistent with and complementary to those of other 
studies, and have addressed several knowledge gaps in the TA TAVI literature.  This may have 
implications on nursing education and practice relevant to caring for TA TAVI patients.  In 
addition, as LOS is often an indicator of outcome measurement on quality of care and resource 
consumption, this study may provide insights into TA TAVI-related practice and policy making.  
Methodologically, this study has merits as well as limitations.  Furthermore, several variables, 
including the Functional Assessment variables and the STS risk score, were underexplored due 
to their high missing data rates in this study.  Nonetheless, it is acknowledged that this study is 
exploratory and preliminary in nature.  Hence, future studies are strongly recommended to 
further validate the findings and explore the underexplored variables in terms of their impact on 
the LOS after TA TAVI patients.   
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Appendix A:  Predicting LOS After TA TAVI:  Data Collection Form 
Chart Number:                Procedure:        
PRE-PROCEDURE PHASE VARIABLES 
DEMOGRAPHICS VARIABLES 
Age:           yrs Sex:    M                 F                  Other 
Date of Referral:        /      /                  Missing Wait Time 1         d 
Date of Acceptance:        /      /                  Missing Wait Time 2       d 
Date of Procedure:        /      /                  Missing Wait Time 3       d 
Status of Referral:             Elective                  In Patient               Missing 
Location of Residence:    FHA       IHA      VIHA     NHA      VCH      Other       Missing    
HISTORY & RISK VARIABLES  
Prior PPM :       Yes           No          Missing Prior Cardiac Interventions:  
 
Prior CABG:     Yes         No        Missing 
 
Prior other Cardiac Surgery:   
                           Yes         No       Missing 
  
Prior PCI:          Yes         No       Missing 
 
Prior SAVR:   
                           Yes         No       Missing 
 
Prior BAV:  
                           Yes         No       Missing 
Prior ICD:          Yes           No          Missing 
Prior Stroke:   Yes            No          Missing 
Chronic Lung  Disease:           
                          Yes            No          Missing  
Diabetes:         Yes            No          Missing 
Prior MI:          Yes            No          Missing    
Prior Atrial Fibrillation:       
                          Yes            No          Missing 
FUNCTIONAL ASSESSMENT VARIABLES 
CSHA CFS:        / 9            Missing Home Support   
 None 
 
 Full-time 
 
 Part-time 
 
 Missing 
Living Situation  
 Lives alone/ Independently 
 
 Lives with family 
 
 Nursing home 
 
 Missing 
ADL:        / 6                      Missing 
IADL:        / 8                     Missing 
MMSE:       / 30                Missing 
5-m Walk:   
              Time 1:      sec      Time 2:      sec      Time 3:     sec      Mean:     sec                     Missing 
PRE-OP STATUS VARIABLES 
NYHA:  
 I        II       III      IV        Missing 
LVEF:  
      %                  Missing 
STS:   
      %                Missing 
Ht:        cm            Missing Wt:       kg            Missing BMI:       kg/m
2                   
 
Hgb:   
       g/L                     Missing 
Creatinine:   
      mol/L                   Missing 
eGFR:  
      ml/min              Missing 
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PERI-PROCEDURE PHASE VARIABLES 
PROCEDURAL FACTORS VARIABLES 
Procedure Start Time:  
                                     Missing 
Procedure End Time: 
                                        Missing 
Procedure Total Time:   
     min 
Valve Type:     
Aortic        Mitral         Both           Missing 
Procedure Type:  
  Native Valve       Valve-in-valve            Missing 
PERI-PROCEDURE STATUS VARIABLES 
While leaving procedure room 
                       Airway Status                                     Extubated         Intubated         Missing 
                       Pulmonary artery catheter:             Yes                     No                     Missing 
                       Chest Drain:                                        Yes                     No                      Missing 
                       Temporary Pacemaker:                    Yes                     No                      Missing 
PERI-PROCEDURE COMPLICATIONS VARIABLES 
≤72  Pacemaker:  
  Yes                 No            Missing 
≤72  Annular Dissection:   
   Yes      No        Missing 
≤72  Atrial Fibrillation:    
  Yes                 No            Missing 
≤72 Cardiac Arrest:  
   Yes      No        Missing 
≤72 Stroke:       Yes           No             Missing ≤72 Perforation:      Yes         No        Missing 
≤72 Bleed:                                                       Yes         No          Missing 
≤72 Blood Transfusion:                                Yes         No          Missing 
≤72 Blood Transfusion  Units:                    1             2             3                 4              5+          Missing     
POST-PROCEDURE PHASE VARIABLES 
LOS IN CRITICAL CARE VARIABLE 
LOS ICU =       hr                                     Missing  
POST-PROCEDURE COMPLICATIONS VARIABLES 
GT72 Pacemaker:   
Yes         No        Missing 
 >72 Perforation:     Yes        No       Missing 
GT72 Atrial Fibrillation:     
Yes         No        Missing 
 >72 Stroke:               Yes        No       Missing 
 >72 Cardiac Arrest:   
Yes         No        Missing 
 
 >72 Bleed:                                            Yes         No        Missing 
 >72 Blood Transfusion:                     Yes         No        Missing 
 >72 Blood Transfusion  Units:         1             2           3        4        5+        Missing        N/A 
DISCHARGE PLANNING VARIABLES 
Discharge Status:   Alive             Deceased    
Discharge Location:  If Alive,   
 Home       Nursing Home       Extended Care/ Rehab      Hospice     Other Hospitals  Other           
Lowest Hgb:  
       g/L                    Missing 
Discharge Hgb:  
       g/L                   Missing 
Highest Creatinine:  
       mol/L           Missing 
Discharge Creatinine:  
       mol/L           Missing 
Date of Discharge:       /      /                               Missing 
OUTCOME OF INTEREST 
LOS =        D 
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Predicting LOS after TA TAVI:  Code Manual 
Study Sample & Eligibility Criteria:  128 medical charts of patients who had symptomatic aortic stenosis, were accepted by the Transcatheter Heart Valve (THV) program, 
underwent TA TAVI procedure at the study center from 2010 to 2014, and were discharged alive. 
# Variable Name Variable Definition Notes 
Chart Information 
1 Chart Number Study sample number assigned to each medical chart 000-999 
2 Procedure Types of TAVI procedure TA TAVI 
Pre-procedure Phase Variables 
Pre-procedure Phase variables pertains to TA TAVI patients' individual characteristics and preoperative status information at the time of acceptance for TA TAVI at 
the study center.  Variables are categorized into four subcategories:  Demographics, History and Risk Factors, Functional Assessment, and Pre-op Status.  
Demographics Variables 
Demographics variables include TA TAVI patient’s socio-demographic characteristics and procedure information from the Date of Referral to the start time of TA TAVI 
procedure.   
3 DOB TA TAVI patient’s date of birth. mm/dd/yyyy 
4 Age TA TAVI patient’s age on arrival for the procedure. Years 
5 Sex TA TAVI patient’s sex at the time of TA TAVI.  M/F 
6 Date of Referral The date when the TA TAVI patient was referred to the Transcatheter Heart Valve (THV) program.  mm/dd/yyyy 
                                                          
7
 Source:  Cardiac Services BC (2008) 
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7 
Date of 
Acceptance 
The date when the TA TAVI patient was accepted by the Transcatheter Heart Valve (THV) program. mm/dd/yyyy 
8 Date of Procedure The date when the TA TAVI patient had the TA TAVI procedure.  mm/dd/yyyy 
9 Wait Time 1 The time period from the Date of Referral to the Date of Acceptance. Days 
10 Wait Time 2 The time period from the Date of Acceptance to the Date of Procedure. Days 
11 Wait Time 3 The time period from the Date of Referral to the Date of Procedure. Days 
12 Status of Referral TA TAVI patient’s status at the Date of Referral:  Elective vs. In-patient 
Elective/  
in-patient 
13 
Location of 
Residence 
The health authority to which TA TAVI patients' primary residences originally belong.  Five health authorities are in BC, 
Canada: Fraser Health Authority (FHA); Interior Health Authority (IHA); Vancouver Island Health Authority (VIHA) 
Northern Health Authority (NHA); Vancouver Coastal Health Authority (VCH). 
FHA/IHA/ 
VIHA/NHA/ 
VCH/ Other 
History & Risk Variables 
History and Risk Factors variables include TA TAVI patients' previous cardiac history, co-morbidities and risk factors prior to the Date of Acceptance.  
14 Prior PPM 
History of permanent pacemaker implantation (PPM) prior to the Date of Acceptance.  This includes patients who had a 
PPM previously, but the device was no longer in place prior to the procedure. 
Y/N 
15 Prior ICD 
History of implantable cardioverter defibrillator (ICD) implantation prior to the Date of Acceptance.  This includes 
patients who had an ICD previously, but the device was no longer in place prior to the procedure. 
Y/N 
16 
Chronic  
Lung Disease 
History of a chronic lung disease prior to the Date of Acceptance.  It included patients with chronic obstructive 
pulmonary disease, chronic bronchitis, or emphysema.  It also included a patient who was currently being chronically 
treated with inhaled or oral pharmacological therapy (e.g., beta-adrenergic agonist, anti-inflammatory agent, 
leukotriene receptor antagonist, or steroid). Patients with asthma or seasonal allergies were not considered to have 
chronic lung diseases in this study. 
Y/N 
17 Diabetes History of diabetes prior to the Date of Acceptance. 
Y/N 
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18 Prior Stroke History of stroke prior to the Date of Acceptance. 
Y/N 
19 Prior MI History of myocardial infarction (MI) prior to the Date of Acceptance. 
Y/N 
20 
Prior Atrial 
Fibrillation 
History of atrial fibrillation (A Fib) prior to the Date of Acceptance. 
Y/N 
21 
Prior Other  
Cardiac Surgery 
History of other cardiac surgeries other than SAVR/repair prior to the Date of Acceptance. 
Y/N 
22 Prior CABG History of coronary artery bypass graft (CABG) surgery prior to the Date of Acceptance. 
Y/N 
23 Prior PCI History of percutaneous coronary intervention (PCI) prior to the Date of Acceptance. 
Y/N 
24 Prior SAVR History of SAVR (SAVR) prior to the Date of Acceptance. 
Y/N 
25 Prior BAV History of balloon aortic valvuloplasty prior to the Date of Acceptance. 
Y/N 
Functional Assessment Variables 
Function Assessment variables include the patient’s functional and frailty status and home environment characteristics prior to the Date of Acceptance.  
26 
Home  
Support 
Defined as the home support services that TA TAVI patients received prior to the Date of Acceptance. Three types of 
Home Support were included in this study:   
#1:  None – independent, no need for home support 
#2:  Full time – require full-time home support 
#3:  Part time- require part-time home support 
None/ 
Full-time/ 
Part-time 
27 
Living  
Situation 
Defined as the living conditions in which TA TAVI patients lived prior to the Date of Acceptance.  Three types of Living 
Situation were included in this study:   
#1:  Lives alone / independently 
#2:  Lives with family 
#3:  Nursing home, including other facilities (i.e., Assisted Living) 
Lives along/ 
Independently/ 
Lives with family/ 
Nursing home 
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28 CSHA CFS 
Refers to the Canadian Study of Health and Aging Clinical Frailty Scale (CSHA CFS) score.CSHA CFS was used to assess TA 
TAVI patients preoperative frailty status.  Scores range from 1 to 9.  Higher scores indicate greater degree of frailty 
status.  Details of scoring are as follows:  ≤ 3:  Well and Fit4-6:  Vulnerable to Moderately Frail7-9:  Severely Frail to 
Terminally Ill 
1-9 
29 ADL 
Refers to the Katz Index of Independence in Activities of Daily Living scale score (ADL).   
ADL was used to assess TA TAVI patients' ability to perform activities of daily living preoperatively.  It assesses six 
functions of bathing, dressing, toileting, transferring, continence, and feeding.  Scores range from 0 - 6.  Higher score 
indicates higher level of independence.  A full score of 6 indicates full function while a score of 2 or less indicates severe 
functional impairment.  Details of scoring are as follows:  
5-6:  High function  
3-4:  Moderate impaired function 
0-2:  Severe impaired function 
0-6 
30 IADL 
Refers to the Lawton Instrumental Activities of Daily Living scale score (IADL).   
IADL was used to assess TA TAVI patients' functional status preoperatively.  It assesses eight domains:  Using telephone, 
shopping, preparing food, housekeeping, doing laundry, using transportation, handling medication, and handling 
finances.  Scores range from 0 (low function, dependent) to 8 (high function, independent).  Details of scoring are as 
follows:  
6-8:  High function  
3-5:  Moderately impaired function 
0-2:  Severely impaired function 
0-8 
31 MMSE 
Defined as the Mini-Mental State Examination (MMSE) scale for assessing patient’s cognitive impairment.  Scores range 
from 0 to 30.  Higher scores indicate less cognitive impairment.  Details of scoring are as follows:  
26-30:  No or little cognitive impairment   
20-25:  Mild cognitive impairment:   
10-19:  Moderate cognitive impairment 
0-9:  Severe cognitive impairment       
0-30 
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32 5-m Walk 
Refers to the 5-m Gait Speed test (5-m Walk test)score.  The 5-m Walk test was used to assess TA TAVI patients' mobility 
capacity and performance.  During the 5-m Walk test in this study, TA TAVI patient was asked to walk, with or without 
walking aids, a distance of five meters for three times (Time 1, Time 2, and Time 3), and then the average of the times 
was calculated.  The last value in this study was taken between 30 days prior to the procedure and the procedure . 
Time 1:  the time in seconds it took the TA TAVI patient to walk 5 meters for the first of three tests. 
Time 2:  the time in seconds it took the TA TAVI patient to walk 5 meters for the second of three tests. 
Time 3:  the time in seconds it took the TA TAVI patient to walk 5 meters for the third of three tests. 
Seconds 
Pre-op Status Variables 
Pre-op Status variables include the TA TAVI patient’s surgical risk assessment and preoperative laboratory results completed with in two weeks prior to the start time 
of the TA TAVI procedure.    
33 NYHA 
The New York Heart Association (NYHA) classification:   
Class I:  Patient has cardiac disease but without resulting limitations of ordinary physical activity. 
Class II:  Patient has cardiac disease resulting in slight limitation of ordinary physical activity, and is comfortable at rest. 
Class III:  Patient has cardiac disease resulting in marked limitation of physical activity. Patient is comfortable at rest. 
Class IV:  Patient has cardiac disease resulting in inability to perform any physical activity without discomfort.  Patient 
has dyspnea at rest that increases with any physical activity. 
Class I/ 
Class II/ 
Class III/ 
ClassIV 
34 LVEF 
The left ventricle ejection fraction (LVEF), indicating the percentage of the blood emptied from the left ventricle at the 
end of the contraction.  Enter a percentage in the range of 1 - 99. If a percentage range is reported, report a whole 
number using the "mean" (i.e., 50-55%, is reported as 53%). 
% 
35 STS 
The Society of Thoracic Surgeons Predicted Risk of Mortality (STS) score, which is one of the commonly used risk profile 
systems for assessing operative risks and identifying high-risk patients for TAVI procedures.  The STS score is comprised 
of over 40 clinical parameters and has been demonstrated to be reliable in assessing operative risk in TAVI patients.  
Higher scores indicate higher operative risk. 
 
36 Ht Height of the TA TAVI patient.  cm 
37 Wt Weight of the TA TAVI patient. kg 
38 BMI 
The Body mass index (BMI) for measuring body fat based on height and weight prior to the date of the TA TAVI 
procedure.  BMI = Weight (kg) / Height
2
(m
2
) 
kg/m
2
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39 Hgb TA TAVI patient's preoperative hemoglobin level prior to the Date of Procedure.   g/L 
40 Creatinine TA TAVI patient's preoperative creatinine level prior to the Date of Procedure.   mol/L  
41 eGFR TA TAVI patient's preprocedure estimated glomerular filtration rate (eGFR) level prior to the Date of Procedure.   ml/min 
Peri-procedure Phase Variables 
Peri-procedure Phase variables include TA TAVI procedural information, TA TAVI-related complications, TA TAVI patients' postoperative status during the period from 
the start time of TA TAVI procedure up to 72 hours after the procedure.    
Procedural Factors Variables 
Procedural Factors Variables include the information of TA TAVI procedure.  
42 
Procedure  
Start Time 
The time when the TA TAVI procedure started. Hr:min 
43 
Procedure  
End Time 
The time when the TA TAVI procedure ended. Hr:min 
44 
Procedure  
Total Time 
The time period from the Procedure Start Time to the Procedure End Time. Minute 
45 Valve Type The types of vavle(s) that TA TAVI procedure was involved:  Aortic or mitral.   
Aortic/ 
 Mitral/ 
 Both 
46 
Procedure  
Type 
The types of TA TAVI.  TAVI involving the replacement of the native aortic valve is called native-valve procedure whereas 
TAVI involving valve implantation within a failed bioprosthesis is called valve-in-valve procedure.  
Native/ VIV 
Peri-procedure Status Variables 
Peri-procedure Status Variables describe TA TAVI patients' postoperative status  within this time period.   
47 Airway Status Indicates whether TA TAVI patient was extubated or intubated prior to admission to the critical care unit. 
Extubated/ 
Intubated 
48 
Pulmonary  
Artery Catheter 
Indicates whether TA TAVI patient had pulmonary artery catheter inserted prior to admission to the critical care unit.  Y 
indicates Yes.  N indicates No.  
Y/N  
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49 Chest Drain 
Indicates whether TA TAVI patient had chest drain inserted prior to admission to the critical care unit.  Y indicates Yes.  
N indicates No.  
Y/N 
50 
Temporary 
Pacemaker 
Indicates whether TA TAVI patient had temporary pacemaker attached prior to admission to the critical care unit.  Y 
indicates Yes.  N indicates No.  
Y/N 
Peri-procedure Complications Variables 
Peri-procedure Complications Variables pertain to the procedure-related complications within this time period. 
51 
≤72  
Pacemaker 
Indicates if TA TAVI patient developed conduction/ native pacer disturbance that required new pacemaker during the 
period from the start time of TA TAVI procedure up to 72 hours after the procedure.  Y indicates Yes.  N indicates No.     
Y/N 
52 
≤72 Atrial 
Fibrillation 
Indicates if TA TAVI patient developed new-onset atrial fibrillation during the period from the start time of TA TAVI 
procedure up to 72 hours after the procedure.  Y indicates Yes.  N indicates No.     
Y/N 
53 ≤72 Stroke 
Indicates if TA TAVI patient had stroke during the period from the start time of TA TAVI procedure up to 72 hours after 
the procedure.  Y indicates Yes.  N indicates No.     
Y/N 
54 
≤72 Annular 
Dissection 
Indicates if TA TAVI patient had annular dissection during the period from the start time of TA TAVI procedure up to 72 
hours after the procedure.  Y indicates Yes.  N indicates No.     
Y/N 
55 
≤72  
Cardiac Arrest 
Indicates if TA TAVI patient had cardiac arrest during the period from the start time of TA TAVI procedure up to 72 hours 
after the procedure.  Y indicates Yes.  N indicates No.     
Y/N 
56 
≤72  
Perforation 
Indicates if TA TAVI patient had perforation during the period from the start time of TA TAVI procedure up to 72 hours 
after the procedure.  Y indicates Yes.  N indicates No.     
Y/N 
57 ≤72 Bleed 
Indicates if TA TAVI patient had bleeding episodes during the period from the start time of TA TAVI procedure up to 72 
hours after the procedure.  Y indicates Yes.  N indicates No.     
Y/N 
58 
≤72 Blood 
Transfusion 
Indicates if TA TAVI patient required blood transfusion during the period from the start time of TA TAVI procedure up to 
72 hours after the procedure.  Y indicates Yes.  N indicates No.     
Y/N 
59 
≤72 Blood 
Transfusion Units 
Indicates how many units of blood products that TA TAVI patient received from blood transfusion during the period 
from the start time of TA TAVI procedure up to 72 hours after the procedure.  Y indicates Yes.  N indicates No.     
Units 
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Post-procedure Phase Variables 
Post-Procedure Phase variables include TA TAVI-related complications and patient-care related complications that occurred from the time of 72 hours post-TA TAVI 
procedure to the discharge.    
LOS in Critical Care Variable 
LOS in Critical Care Variable refers to the length of stay in the intensive care unit.   
60 LOSICU Defined as the length of stay of TA TAVI patient in the critical care after TA TAVI. Recorded in hours. Hours 
Discharge Planning Variables 
Discharge Planning Variables pertain to TA TAVI patients' information and laboratory values for discharge planning.  
61 
Discharge  
Status 
Indicates if TA TAVI patient was alive or deceased at the time of discharge.  
Alive/ 
Death 
62 
Discharge  
Location 
Indicates the locations to which TA TAVI patient was discharged, including 1) Home; 2) Nursing Home; 3) Extended Care/ 
Rehab  4) Hospice; 5) Other Hospitals; and 6) Other. 
Vary 
63 
Lowest  
Hgb 
Defined as the lowest value of hemoglobin that TA TAVI patients had during hospitalization.   g/L 
64 
Discharge  
Hgb 
Defined as the value of TA TAVI TA TAVI patient's hemoglobin upon discharge.   g/L 
65 
Highest  
Creatinine 
Defined as the highest value of creatinine that TA TAVI patients had during hospitalization. mol/L 
66 
Discharge  
Creatinine 
Defined as the value of TA TAVI patient's creatinine upon discharge.   mol/L 
67 Date of Discharge Defined as the date when TA TAVI patient was discharged alive from the hospital.  mm/dd/yyyy 
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Post-procedure Complications Variables 
Post-procedure Complications Variables pertain to the procedure-related complications within this time period. 
68 
>72  
Pacemaker 
Indicates if TA TAVI patient developed conduction/ native pacer disturbance that required new pacemaker during the 
period from the time of 72 hours post-TA TAVI procedure to the discharge.  Y indicates Yes.  N indicates No. 
Y/N 
69 
>72 Atrial 
Fibrillation 
Indicates if TA TAVI patient developed new-onset atrial fibrillation during the period from the time of 72 hours post-TA 
TAVI procedure to the discharge.  Y indicates Yes.  N indicates No. 
Y/N 
70 >72 Stroke 
Indicates if TA TAVI patient had stroke during the period from the time of 72 hours post-TA TAVI procedure to the 
discharge.  Y indicates Yes.  N indicates No. 
Y/N  
71 
>72  
Cardiac Arrest 
Indicates if TA TAVI patient had cardiac arrest during the period from the time of 72 hours post-TA TAVI procedure to 
the discharge.  Y indicates Yes.  N indicates No. 
Y/N 
72 
>72  
Perforation 
Indicates if TA TAVI patient had perforation during the period from the time of 72 hours post-TA TAVI procedure to the 
discharge.  Y indicates Yes.  N indicates No. 
Y/N 
73 >72 Bleed 
Indicates if TA TAVI patient had bleeding episodes during the period from the time of 72 hours post-TA TAVI procedure 
to the discharge.  Y indicates Yes.  N indicates No. 
Y/N 
74 
>72 Blood 
Transfusion 
Indicates if TA TAVI patient required blood transfusion during the period from the time of 72 hours post-TA TAVI 
procedure to the discharge.  Y indicates Yes.  N indicates No. 
Y/N 
75 
>72 Blood 
Transfusion Units 
Indicates how many units of blood products that TA TAVI patient received from blood transfusion during the period 
from the time of 72 hours post-TA TAVI procedure to the discharge.  Y indicates Yes.  N indicates No. 
Units 
Outcome of Interest 
76 LOS 
Defined as TA TAVI patient's hospital stay from the date of the TA TAVI procedure to the date of discharge, excluding 
death. Recorded in days. 
Days 
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Appendix C:  Transcatheter Heart Valve (THV) Program Functional Assessments 
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